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ABSTRACT
The amygdala is a multinucleate body located deep in the temporal lobe. Part of the 
limbic system, the amygdala has been shown to be a crucial region in the neural 
processes underlying emotion. The central nucleus of the amygdala is the output 
nucleus for the amygdala, and is believed to be maintained under a high level of 
inhibition from a network of inhibitory neurones contained within a larger structure 
called the central extended amygdala. This thesis investigates the synaptic 
physiology of neurones of the central amygdala. This study has utilized whole cell 
patch pipette recording methods to record the currents underlying excitatory and 
inhibitory synaptic responses in these neurones and a range of pharmacological 
agents to determine the receptors mediating these currents.
Excitatory transmission in the central amygdala was found to be mediated by the 
activation of glutamate receptors. These receptors were found to be of the AMPA 
and NMDA types, with sensitivity shown to the antagonists CNQX and D-APV 
respectively. Inhibitory synaptic currents in these neurones were found to result 
from activation of GABA receptors. Two types of GABA receptors were identified 
according to sensitivity to the antagonist bicuculline, both contributing to synaptic 
currents. The first type was a typical GABAa receptor that displayed sensitivity to 
low concentrations of bicuculline and was positively modulated by 1,4- 
benzodiazepines. The second type was an atypical GABA receptor that had 
pharmacological properties consistent with GABAc receptors found in retina 
(insensitivity to low concentrations of bicuculline, but sensitivity to the antagonist 
TPMPA) and properties normally associated with particular subtypes of GABAa 
receptors (sensitivity to 1,4-benzodiazepines and barbiturates). The specific effect of 
the 1,4-benzodiazepine was unlike any previously reported in that the currents 
mediated by these atypical GABA receptors were partially blocked by these agents. 
These receptors also displayed reduced sensitivity to barbiturates and insensitivity to 
the anaesthetic propofol when compared to typical GABAa receptor mediated
currents.
The synaptic distribution of these two GABA receptor types was investigated by 
studying the sensitivity of evoked and spontaneous inhibitory synaptic currents to 
the antagonists bicuculline and TPMPA. The latter events indicated that the 
predominantly activated synapses are located on the dendritic regions of these 
neurones and contain a mixture of both types of GABA receptor. These synaptic 
events could be evoked electrically by stimulating in the region of the intercalated 
cell masses, positioned laterally to the central amygdala, or as part of a disynaptic 
circuit from the basolateral amygdaloid complex. A population of large spontaneous 
events that occur at very low frequency in control conditions were found to be 
mediated by GABAa receptors only. These synaptic responses could be evoked 
electrically medially to the central amygdala.
These experiments show that there exists a novel type of GABA receptor in the 
central amygdala that is insensitive to bicuculline, sensitive to TPMPA and 
negatively modified by the classical 1,4-benzodiazepines. Secondly, these novel 
receptor types are selectively targeted to particular synapses in the neurone, in a 
pathway dependant manner. The third finding is that the lateral division of the 
central amygdala receives inhibitory input following the flow of input through the 
amygdala from the lateral to medial parts, as well as medial to lateral inhibition 
from as yet unidentified sources.
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1. INTRODUCTION
1.1. THE BRAIN
The brain, like all other organs of the body, is an organisation of differentiated cells 
that perform specific functions within the processes required to sustain the life of 
the body. What sets the brain apart from other organs, is the degree of specialisation 
of cells within the brain, the organisation of these units into multiple functional 
modalities, the complexity of the functions that this cellular organisation achieves, 
and the degree by which the brain interacts with and indeed presides over the other 
functions of the body.
The brain and nervous system are composed of billions of specialised cells called 
neurones, accompanied by even more non-neuronal support cells called neuroglial 
cells. Neurones have evolved into highly organised cellular structures, which are 
capable of conducting electrical signals, often over very large distances, and 
communicating with each other at specialised structures called synapses. Some 
neurones also communicate with non-neuronal cells, such as muscle fibres and 
endocrine cells by releasing substances onto these cells at specialised junctions, 
such as the neuro-muscular junction. Neurones are organised into patterns of 
communication called circuits, which link particular subsets of neurones into a 
functional unit. These communicational patterns also direct the anatomical 
distribution of those neurones into groups called nuclei. The interaction of these 
nuclei through electrical communication of neurones within them are the basis of 
brain function.
The functions of the nervous system are generally classified into sensory, motor, and 
behavioral aspects. Sensory functions receive and process information about the 
internal and external environment of the body. Functional modalities within this 
group include the visual system, auditory system, olfactory system, vestibular 
system, and the somatosensory system. Motor functions control the movement of the
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body through coordinated innervation of muscle. The neuronal mechanisms 
underlying the behavioral functions of the brain are less understood than sensory 
and motor functions. These functions include cognition, emotion, memory and 
consciousness and involve specialised systems such as the association cortex, the 
limbic system and the autonomic nervous system.
1.2. THE LIMBIC SYSTEM AND EMOTION
1.2.1. Historical perspectives
James W. Papez is credited with the original notion that the complex behavioral 
processes that we collectively coin in the word ‘emotion’ occur in the circuitry of a 
group of nuclei, in the limbic lobe. This lobe, first described by the french anatomist 
Broca, was originally described as the cerebral cortex rimming the corpus collosum 
on the medial aspect of the hemispheres. This includes the cingulate and 
hippocampal gyri (and the isthmus which connects them), and various gyri 
associated with the olfactory system. Evidence accumulated that the hypothalamus 
was intimately involved in the expression of emotion. Papez reasoned that emotion 
was a process that occurred in consciousness and that higher cognitive processes 
affect emotion. Thus the neural system that formed emotion must connect higher 
cortical centres involved in cognitive function with the hypothalamic region where 
emotional expression occurred. He proposed a neural circuit which included the 
mammilary body, the anterior nuclei of the thalamus, the gyrus cinguli and the 
hippocampus, which ‘may elaborate the functions of central emotion as well as 
participate in emotional expression’ (Papez, 1937).
Just two years after Papez had published his proposed emotion circuit Klüver and 
Bucy published a study describing the effects of temporal lobotomy in rhesus 
monkeys (Klüver & Bucy, 1939). In this study, the authors noted that among the 
effects of the temporal lobotomy were ‘marked changes to emotional behavior or
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absence of emotional reactions in the sense that the motor and vocal reactions 
generally associated with anger and fear are not exhibited’. These behavioral effects 
(later to become known as the Kluver-Bucy syndrome) led Paul MacLean to expand 
the emotion circuit proposed by Papez, to include hypothalamic regions, the septal 
area, nucleus accumbens, orbitifrontal cortex, and the amygdala (MacLean, 1949). 
This expanded version of Papez’s circuit has now become known as the limbic 
system.
1.2.2. Limbic Structures participate in emotional processes
The modern view of the limbic system is a complex neuronal circuit composed of 
extensive direct and indirect connections between various cortical areas, cingulate 
gyrus, hippocampus, thalamus, amygdala and hypothalamus.
The hypothalamus acts on the endocrine system and the autonomic nervous system 
to control a variety of regulatory systems. It contains several classes of peptidergic 
neuroendocrine cells that control the endocrine system by releasing neuroendocrine 
products either directly into general circulation via the posterior pituitary or 
indirectly via the portal circulatory system in median eminence. The hypothalamus 
also functions as the head ganglion of the autonomic system. It sends neuronal 
outputs to the brainstem and spinal cord that innervate preganglionic autononic 
neurones. Stimulation of the hypothalamus has been shown to be able to produce all 
of the autonomic and somatic effects of emotional behavior, even in the absence of 
all other parts of the limbic system. The role of this structure is thus considered to be 
the point of convergence of the processes occuring in the limbic system which 
activates the autonomic and somatic responses associated with emotional response.
Limbic structures that provide input to the hypothalamus include the amygdala and 
the hippocampus. The hippocampus has been intensely studied in recent years as a 
site where processes of memory and learning are though to occur. It is well 
established that hippocampus integrates and relays cortical information to the 
hypothalamic region via substantial connections passing through the fornix, 
however its role in the formation and expression of emotion is not well understood.
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In contrast, the amygdala has been shown to be a critical structure in emotional 
processes. Lesioning the amygdala produced marked effects on emotional behavior 
-  particularly fear (Rosvold et al, 1954). Projections from the amygdala to thalamic 
and brainstem regions have been demonstrated anatomically (Otterson, 1980; 
Otterson, 1981) and functionally (Clugnet et al, 1990), as have connections with the 
limbic corticies (Pascoe & Kapp, 1987).
Various studies have shown that lesions or ablations of the limbic corticies -  the 
orbitofrontal cortex, the cingulate gyrus and cortical regions of the temporal lobe 
have effects that alter emotional responses (Klüver & Bucy, 1939). Prefrontal 
lesioning (frontal lobotomy) reduced aggression in primates and was used for a 
short time as a treatment for severely mentally ill humans to reduce anxiety. 
Furthermore, stimulation of prefrontal cortex produces a range of autonomic 
responses, indicating association with hypothalamic or brainstem regions (Galsema 
et al, 1987). The lesioning of the temporal portion of limbic association cortex also 
resulted in emotional abnormalities. Stimulation in this area produces emotional 
expression particularly feelings of fear. These regions have also been shown to 
project into the amygdala and hippocampus.
1.1.1. What is emotion?
The concept of the limbic system indroduced by Papez and later expanded by 
MacLean, invoked an ideal that emotions were the net result of neuronal processes 
occuring within this system. However, the centralization of all emotional processes 
to a defined circuitry within the limbic system has not been demonstrated, and this 
concept of a dedicated emotional system is faultering under increasing scrutiny 
(LeDoux, 2000; Rogan & LeDoux, 1996).
The question ‘what is emotion’ was posed in the late nineteenth century by William 
James (James, 1884) but has remained unanswered now for over a century. Despite 
the fact that our own experience of emotions allows us to know intuitively what they 
are, no scientific definition of emotion has become accepted (LeDoux, 1995; 
Simonov, 1997). Descriptions of emotion are also vague and non-committal, which 
perhaps arises from the varied and subjective nature of emotion and our inability to
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rationalise a feeling into a measurable, definable entity. Emotion has been described 
as a ‘short label for a very broad category of experiential, behavioural 
sociodevelopmentai, and biological phenomena' (Cacioppo & Gardner, 1999), or 
consisting of two dimensions where on one axis emotional states range from 
positive (happy) to negative (fearful or angry), and the other axis low to high arousal 
states (Gallagher & Chiba, 1996). Alternately, some theorists have tried to 
catagorise emotion into basic emotions which in combination give rise to more 
complex emotions (Izard, 1992), while others have argued that even these ‘basic 
emotions’ may not be emotions at all (Ortony & Turner, 1990).
An alternative to trying to define emotion as a neurological entity, is to describe 
different expressions of emotion, such as such as guilt, embarrassment, anger, 
happiness or fear, and to relate them and even measure them according to a range of 
physical manifestations of these emotional states. By studying these narrow models 
of emotion it is thought that common mechanisms of all emotions may be 
ascertained, and the organization of all emotional circuitry established (LeDoux, 
1995).
The most commonly researched and best-understood expression of emotion is fear 
(LeDoux, 1996). This understanding has come from the study of emotional 
disorders in humans related to the regulation of fear, anxiety, phobia, panic and 
post-traumatic stress, and the relation of the physiological manifestations of these 
disorders in humans to behavioural measures that can be obtained from animal 
models of fear. Though no absolute evidence exists that any animal model of fear is 
actually producing fear as experienced by humans, the behavioural correlates and 
physiological determinants studied are common across mammalian species in 
similar experimental fear paradigms (LeDoux, 1996). These studies have allowed 
researchers to examine the neuronal pathways involved in the control of fear 
reactions, and perhaps in the formation of the emotion itself, rather than studying the 
emotion on subjective grounds. They have demonstrated that at least in the case of 
this emotion, it is not only the regions of the brain previously included in the limbic 
system which have a role (LeDoux, 2000).
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1.2.4. Fear conditioning
The study of fear most commonly involves the use of a behavioural model of fear 
called fear conditioning. This learning paradigm is a development from the 
observations of Pavlov, whose work on salivation in dogs in response to visual and 
acoustic stimuli led to the model of classical conditioning where conditioned stimuli 
(CS) are paired with unconditioned stimuli (US) (Pavlov, 1928). One of the 
conditioning models developed by Pavlov -  defense conditioning, has now become 
known as fear conditioning.
The simplest form of fear conditioning involves the pairing of an innocuous CS, 
such as an auditory or a visual stimuli, with a noxious US such as a footshock. After 
just a few such pairings, or even a single pairing, behaviour consistent with defense 
and fear is exhibited in response to either the CS, the US or both.
Perhaps the most valuable findings arising from the use of fear conditioning in 
behavioural studies arose from studies using selective ablation of particular regions 
of the brain to disrupt the acquisition or expression of the conditioned state. In 
particular, lesioning studies of the amygdala, which had been shown to decrease 
responses to threatening experiences in monkeys (Rosvold et a l, 1954) and cats 
(Schreiner & Kling, 1956), were shown to block fear conditioning (Davis et al., 
1993; LeDoux et al., 1990; Sananes & Davis, 1993), or the expression of the fear 
conditioned state after acquisition (Davis et al., 1993; Hitchcock & Davis, 1991; 
Hitchcock & Davis, 1986).
A number of axonal tracing studies (Kapp et al., 1985; Kapp et al., 1985; LeDoux et 
a l , 1990; McDonald, 1991; McDonald, 1991; Ottersen, 1980; Ottersen, 1981; 
Ottersen, 1982; Ottersen & Ben-Ari, 1979) and electrophysiological studies 
(Clugnet et al., 1990; Ono et al, 1995) have identified the sources of input to the 
amygdala and targets of amygdala output, and have led to the formation of a 
putative fear conditioning circuit. This circuit (Figure 1.1) places the amygdala at a 
position where processed and unprocessed sensory information is received, and after 
presumably some integration of this information has occurred, output is sent to an
i
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Figure 1.1. Schematic of proposed neuronal circuits involved in emotions 
(adapted from [LeDoux,1993; Chamey,1996]).
Major excitatory pathways indicated by heavy unbroken arrows, major 
inhibitory pathways indicated by heavy broken arrows and minor/indirect 
inhibitory pathways indicated by light dashed arrows.
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effector system in the hypothalamus or brainstem. Furthermore, the amygdala has 
now become widely accepted as the region of the brain where this form of 
associative learning occurs (Armony & LeDoux, 1997; Davis, 1992; Davis, 1994; 
Faneslow & LeDoux, 1999).
1.3. THE AMYGDALA
The amygdala is a complex of connected nuclei situated medially in the temporal 
lobe. In the primate, cat and rat, it comprises of four main nuclei; Lateral (LA), 
Basolateral (BLA), Basomedial (BMA) and Central Amygdala (Ce), several smaller 
accessory' nuclei, and an associated area of cortex (Figure 1.2.). The four main 
nuclei are also composite of smaller divisions, according to connectivity and 
cytoarchitectonic distinctions. Although nomenclature across the species is 
somewhat divergent, corresponding amygdaloid nuclei and connectivity between 
these nuclei has generally been described (Pare & Smith, 1998).
Anatomically, amygdaloid nuclei are grouped into the laterally situated Basolateral 
Amygdaloid complex (consisting of the LA, BLA and BMA), the medially situated 
Central Extended Amygdala (consisting of the Ce, the lateral bed nucleus of the stria 
terminalis (BNST) and the sublenticular substantia innominata (SI) (Sun et al., 
1994). The overlying dorsolateral region of cortex contains neurones that closely 
resemble those of the basolateral complex (McDonald, 1992). Furthermore, several 
cortical inputs to the basolateral complex also project to this region, which then 
projects to basolateral and central amygdaloid neurones (Turner & Zimmer, 1984). 
For these reasons, these cortical regions are often referred to as the cortical nuclei of 
the amygdala (McDonald, 1992).
Separating the cortical nucleus and basolateral complex is a dense fibre bundle 
called the external capsule (EC) and a similar but somewhat smaller bundle between 
the basolateral amygdaloid complex and the central nucleus is called the 
longitudinal association bundle (lab) (Figure 1.2.). Lying within these dense fibre
BMA
ACort
Figure 1.2. Schematic diagram of the rat amygdala in coronal section. 
Abbreviations- ACort - cortical nucleus of the amygdala, B - basal nucleus 
of meynert, BLA - basolateral amygdala, BMA - basomedial amygdala, 
CeL - central amygdala, lateral division , CeM - central amygdala, medial 
division, CPu - caudate putamen, EC - external capsule, ICM - intercalated 
cell masses, LA - lateral amygdala, lab - longitudinal association bundle, 
MeA - medial amygdala, OT - optic tract, Pir - piriform cortex and PRh - 
perirhinal cortex.
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tracts are heterologous clumps of neurones called the intercalated cell masses (ICM) 
(Millhouse, 1986).
1.3.1. The Basolateral Amygdaloid Complex
The basolateral amygdaloid complex has been shown in a variety of species to 
contain two principle types of neurones (McDonald, 1992) -  a pyramidal like 
neurone, densely covered in spines, and a stellate neurone with an oval somata and 
very few spines. The pyramidal type is the predominate type of neurone in the 
complex, and although its size does vary across nuclei these cells are larger than the 
stellate cells. Morphologically similar to cortical pyramidal neurones, the 
amygdaloid pyramidal neurones contain glutamate and project out of their nuclei. 
The smaller and less prominent stellate cells contain gamma-amino butyric acid 
(GABA) and neuropeptides, and generally project locally within their nuclei (Davis 
et al., 1994). Though cell size has been used to identify the boundaries of LA, BLA 
and BMA, these regions largely contain homogenous populations of cell types. As 
such other aspects, such as cell density, connectivity and immunolabelling are also 
used for defining divisions within these nuclei.
The LA is the most dorsal nucleus in the rat basolateral amygdaloid complex along 
the entire rostrocaudal extent of the complex. It lies between the external capsule on 
its lateral aspect and the intermediate capsule medially. Based on cell density, 
immunoreactivity to the enzyme acetylcholine esterase (AChE), timm staining, and 
connectional data, the rat LA has been divided into dorsolateral, ventrolateral, and 
medial divisions (Savander et al., 1996; Turner & Zimmer, 1984).
The BLA (also referred to as the basal nucleus) is the largest and most complex 
nucleus of the rat basolateral amygdaloid complex. It lies ventrally to the LA for the 
most part between EC and IC. Though the border between LA and BLA is not 
clearly defined by fibres, the BLA can be distinguished from LA by the larger size 
of its neurones and its darker appearance under the light microscope. In all species
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studied, the BLA contained the largest amygdaloid neurones (Price et al., 1987). 
Using similar histochemical and cytological methods, Turner and Zimmer describe 
five subdivisions in the rat BLA -  anterior, ventral, middle, medial, and posterior 
parts, with the middle subdivision further divided laterally and medially (Turner & 
Zimmer, 1984), whereas Savander et al subdivide the BLA into three subdivisions -  
magnocellular, intermediate and parvicellular (Savander et al,  1995) . The latter 
study also incorporated connectionai observations in its nomenclature and will be 
used in the remainder of this thesis.
The BMA (or accessory basal nucleus) is the most ventral nucleus of the basolateral 
complex, lying in the caudal half of the complex. This region in the cat and primate 
appear quite homologous, and in these species is clearly subdivided into 
magnocellular, parvicellular and superficial divisions (Price et al., 1987). In 
contrast, the rat BMA does not show clear subdivisions. The most homologous 
region in the divisions of cat and primate is an area similar to the superficial 
division, which like that of cat and primate, has larger cells and higher AChE 
immunoreactivity. However, based on connectivity, this region has since been more 
recently described as part of the amygdalohippocampal area (Savander et al., 1996).
1.3.2. The Central Extended Amygdala
The concept of the central extended amygdala (CEA) arose from initial observations 
by Johnston (Johnston, 1923) that during development and into the adult, the bed 
nucleus of the stria terminalis and the centromedial amygdaloid nuclei formed a 
continuum. This was further demonstrated and broadened to include the 
sublenticular substantia innominata by de Olmos (De Olmos, 1972). Subsequent 
studies have shown similarities between the cell types within these regions (Alheid 
et al., 1998; McDonald, 1992; Shimada et al., 1989).
The central amygdala
The CeA in all mammalian species studied has two prominent divisions based on 
cell morphology -  lateral (CeL) and medial (CeM) (Alheid et al., 1995; McDonald,
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1992). In the rat, the CeL has been further divided into two subdivisions- the core 
region of lateral (CeL) and the lateral capsular division (CeLC), and the CeM has 
been divided into an anterodorsal region (CeMad), a anteroventral region (CeMav), 
and postoventral region (CeMpv) based on cytoarchitectural grounds (Alheid et al 
1995; Cassell & Gray, 1989; McDonald, 1982; Price et al., 1987). Others have also 
included an intermediate division lying between the CeL and CeM based on 
counterstaining using Nissl and golgi staining methods (McDonald, 1982) and inter- 
and intra-connectivity of these divisions (Jolkkonen & Pitkanen, 1998).
The CeM contains neurons with ovoid, fusiform or piriform shaped somata. These 
cells have been grouped into two types based on dendrite morphology -  one with 
sparsely spined thin primary dendrites that branch into spiny secondary dendrites, 
and one with thick non-spiny dendrites (Price et al., 1987),(Cassell & Gray, 
1989),(McDonald, 1982). Axons of CeM neurons project out of the CeM into stria 
terminalis and the ventral amygdalofugal pathway, with only a small number of 
local collaterals remaining in the CeM. Thus these neurones have been described as 
the primary projection neurones of the central amygdala (McDonald, 1982).
The principal cell type in the CeL and CeLC has an ovoid or round soma and 
medium density of spines which increases on the secondary dendrites. The axons of 
these neurones collateralise locally onto other medium spiny neurons in CeL, and 
project out of the CeL to the bed nucleus of the stria terminalis (McDonald, 1982; 
Sun & Cassell, 1993). These neurons also feature spinelike protrusions on the initial 
segment, similar to those seen in the striatum and cerebral cortex that have been 
found to be post synaptic specialisations. Two other cell types have been described 
in the CeL (but excluded from the capsular region) by Cassell and Gray (Cassell & 
Gray, 1989). One is a small population of larger neurones with long piriform somata 
and thick aspinous primary dendrites. Primary dendrites of these neurones either 
emerge from the apical position, bifurcate at about 1 Ojim from the perikaryon and 
extend away from the cell in the same direction as the primary dendrite, or emerge 
basally, bifurcate at about the same distance and radiate out from the cell. The 
second is a population of smaller ellipsoid shaped neurones with no spines, and 
short dendrites emerging from the most distal ends of the soma (Cassell & Gray, 
1989).
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The intermediate division of the CeA is only described in rat, using counterstaining 
(McDonald, 1982) or connectional data (Pitkänen et al., 1997). The cells of this 
region were described by McDonald as being very similar to those of CeM, and 
having dendritic fields overlapping those of CeM. The same study indicated that the 
axons of these neurones branch locally in the vicinity of the cell. This observation 
was supported by a later study using anterograde tracing that indicated that the 
majority of Cel projections were intradivisional (Pitkänen et al., 1997).
Numerous studies have demonstrated that the CeA has a high density of GABAergic 
neurones (Jongen-Relo & Amaral, 1998; McDonald & Augustine, 1993; Nitecka & 
Ben-Ari, 1987; Pitkänen & Amaral, 1994), and the highest density of GABAergic 
terminals in the amygdala (Nitecka & Ben-Ari, 1987). The CeA has also been found 
to contain a high density of cells containing a variety of neuropeptides including 
substance P (SP), vasoactive intestinal polypeptide (VIP), neurotensin (NT), galanin 
(GAL), somatostatin (SOM) corticotrophin-releasing factor (CRF) and enkephalin 
(ENK) (Roberts, 1992). VP, NT, SOM and CRF reactive neurones were found on 
numerous cell types in both CeL and CeM, whereas SP and GAL reactive neurones 
were confined to the aspiny ovoid and pyrimaform neurons of CeM (Cassell et al., 
1986; Cassell & Gray, 1989; Roberts, 1992).
The bed nucleus o f the stria terminalis
Golgi studies have shown that the neurones of the bed nucleus of the stria terminalis 
(BNST) are identical to corresponding regions in the Ce. The anterodorsal part of 
lateral BNST contains both the predominate medium spiny and the spine sparse 
neurones found in the CeL, whereas the ventro posterior parts of lateral BNST 
contain neurones identical to those of the CeM (Alheid et al., 1995; McDonald, 
1992). The BNST has also been shown to produce a number of the neuropeptides 
found in Ce neurones, including CRF, NT, SP and SOM (Shimada et al., 1989) and 
to also contain a high density of GABAergic neurones (Nitecka & Ben-Ari, 1987). 
The medial BNST shows cellular homology to a region medial to the Ce, which is 
described as medial amygdala in some studies.
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Sublenticular substantia innominata
This region lies between the globus pallidus and the lateral proptic-lateral 
hypothalamic grey region (dorsally to ventrally), merging with the BSTL and 
BSTM at its rostromedial aspect and the CeM caudolaterally (de Olmos et al., 
1985). Neurones of the SI are a homologous population medium sized spindle 
shaped neurones which have dendritic fields that freely overlap those of the CeM 
(McDonald, 1982).
1.4. PROJECTIONS TO THE AMYGDALA
Numerous axonal tracing studies have revealed each amygdaloid nucleus receives 
input from multiple yet distinct brain regions generally in a non-overlapping 
manner. Based on axonal tracing studies, lesioning studies and electrophysiological 
recordings, the basolateral amygdaloid complex is believed to be the sensory input 
station of the amygdala (Davis et al., 1994; Pitkänen et al., 1997). Highly processed 
sensory information from a variety of cortical and subcortical regions arrives either 
directly to regions in these nuclei or via the cortical nuclei of the amygdala 
(Mascagni et al., 1993).
The LA has been shown to receive convergent inputs from thalamic (lateral and 
medial geniculate nuclei) and secondary cortical areas of the visual and auditory 
systems (temporal cortex) directly or via the perirhinal cortex (LeDoux, 1993; Ono 
et al., 1995; Romanski et al., 1993). Somatosensory information from the medial 
geniculate nucleus, the supra geniculate nucleus and the posterior intralaminar 
nucleus arrives directly or via the temporal cortex and insular cortex, with 
somatosensory information from the ventral postolateral nucleus and the ventral 
postomedial nucleus. Gustatory information also arrives from the ventral 
postomedial nucleus via insular cortex (Turner and Herkenham, 1991).
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The BLA and BMA receive information from some sensory modalities, including 
somatosensory and olfactory information, and spacial and contextual input from the 
hippocampus, project to the BLA and BMA nuclei (Maren, 1999). Olfactory 
information inputs to both the BLA and BMA from olfactory bulb via piriform 
cortex while somatosensory information arrives directly to BMA from the medial 
posterior complex and the parabrachial nucleus. Visual and auditory responses are 
relayed to the BMA and BLA after entering the LA as part of the intra-amygdaloid 
circuitry, which will be discussed later.
The central nucleus also receives both ascending and descending extra-amygdaloid 
input. Descending projections to Ce arrive from cortical areas and thalamic areas. 
Cortical regions projecting to Ce include viscerosensory and somatosensory regions 
of insular cortex (infralimbic cortex, dysgranular insular cortex, posterior insular 
cortex, ventral agranular insular cortex and dorsal agranular insular cortex) (Kapp et 
al., 1985; Mcdonald et al., 1996; McDonald et al., 1999; Ottersen, 1982; Pascoe & 
Kapp, 1987; Saper, 1982; Veinante & Freund-Mercier, 1998; Yasui et al., 1991), 
medial prefrontal cortex (Kapp et al., 1985; Ottersen, 1982), temporal cortex (areas 
2 and 3 to CeLC only) (Mascagni et al., 1993), perirhinal cortex (to CeLC only) 
(McDonald et al., 1999), entorhinal cortex (rostral ventrolateral entorhinal area and 
rostral dorsolateral entorhinal area) (McDonald & Mascagni, 1997; McDonald et 
al., 1999), and the amygdalopyriform transition area (McDonald et al., 1999; 
Shammah-Lagnado & Santiago, 1999). Thalamic regions projecting to Ce include 
the paraventricular, parataenial, interanteromedial, and parafascicular nuclei, the 
basal nucleus of the ventromedial complex, the medial division of the medial 
geniculate complex, posterior intralaminar nucleus and the medial posterior 
complex (LeDoux et al., 1990; Moga et al., 1995; Ottersen & Ben-Ari, 1979). 
Ascending projections include hypothalamic input from the ventromedial nucleus, 
ventral premammilary nucleus, lateral hypothalamus and the posterior hypothalamic 
nucleus (Canteras et al., 1994; Russchen, 1982; Veening, 1978; Vertes et al., 1995), 
and brainstem input from dorsal raphe, parabrachial nuclei, locus coeruleus, 
periaqueductal gray, various tegmental regions, ventrolateral medulla and the 
nucleus of the solitary tract [(Bernard et al., 1989; Bernard et al., 1993; Hallanger & 
Wainer, 1988; Halsell, 1992; Jia et al., 1997; Krukoff et al., 1993; Ottersen & Ben- 
Ari, 1978; Rizvi et al., 1991; Roder & Ciriello, 1993; Russchen, 1982; Veening, 
1978; Vertes, 1991).
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1.5. INTRAAMYGDALOID PROJECTIONS
Interconnection between the nuclei (internuclear), and indeed the divisions within 
each nuclei (intranuclear) are highly ordered and quite complex. The passage of 
information, with a few exceptions (Savander et al., 1997), has largely been 
generalised to follow a lateral to medial progression from the basolateral 
amygdaloid complex input station to the central extended amygdala as the output 
station.
1.5.1. Projections originating in Lateral Amygdala
Axonal tracing studies using tritiated amino acids or the anterograde tracer 
Phaseolus vulgaris leucoagglutin (Pha-L) have demonstrated that neurones of the 
LA have three main internuclear targets -  the BLA, the BMA and the CeL, but they 
also project heavily within the subdivisions of the LA itself (Krettek & Price, 1978; 
Pitkänen et al., 1997; Pitkänen et al., 1995; Smith & Pare, 1994).
In the rat (Pitkänen et al., 1995), the lateral division of the LA projects primarily to 
the BMA, but also projects substantially to the parvicellular division of the BLA, 
and the amygdalohippocampal area from its caudal end. Light projections were also 
reported in medial amygdala and the cortical amygdaloid nuclei. The medial 
division has been reported to project heavily to the BMA, the capsular region of the 
CeL and the periamygdaloid cortex. Medium density projections are seen in both 
divisions of the BLA and various corticoamygdaloid areas. The CeL and CeM 
receive very light LA innervation only, which has now been questioned by the 
author (A. Pitkänen, 1999, personal communications). A similar pattern of 
projections was described for the cat (Krettek & Price, 1978; Smith & Pare, 1994) 
where the laterally situated shell region was found to project primarily to the BMA 
whereas the medial core region projects to the BLA. In contrast to the study in the 
rat both regions of LA were found to project to CeL, but as for the rat no projections 
were identified in the CeM.
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Intranuclear projections are heavy and unidirectional between the divisions of the 
LA (dorsolateral projecting to ventrolateral and medial) but light within these 
divisions (Pitkänen et al., 1997).
1.5.2. Projections originating in Basolaterai Amygdaia
The BLA has also been shown to have heavy intranuclear projections, however in 
contrast to the LA these are mainly confined within the divisions (magnocellular, 
intermediate and parvicellular). There is light interdivisional projections between the 
parvicellular division and the other divisions which may also be reciprocal (Pitkänen 
et al., 1997).
Internuclear projections originating in the BLA primarily target the CeM and 
nucleus of the lateral olfactory tract (NLOT) and periamygdaloid cortex in the cat, 
and the amygdalohippocampal area in the rat (Krettek & Price, 1978; Pare et al., 
1995; Savander et al., 1997). The BLA also projects back to the LA (Savander et al., 
1997), contrary to the generalisation of lateral to medial progression of innervation 
through the amygdala (Amaral et al., 1992; McDonald, 1992). BLA projections 
primarily originate in the parvicellular division in the rat, with the only other 
internuclear projection from the magnocellular division to NLOT (Pitkänen et al., 
1997).
1.5.3. Projections originating in the Basomedial Amygdala
Like the BLA, the BMA has extensive inerdivisional projections within its 
subdivisions (magnocellular and parvicelluar), however unlike the BLA and LA 
these divisions do not appear to interconnect (Pitkänen et al., 1997).
The internuclear targets of BMA includes the CeM, NLOT, the periamygdaloid 
cortex, the lateral and anterior conical nuclei, the central division of medial 
amygdala, and a reciprocal projection back to LA (Krettek & Price, 1978; Pare et
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al., 1995; Savander et al., 1997; Savander et al., 1997). These projections arise from 
both divisions of the BMA (Pitkänen et al., 1997).
1.5.4. Intrinsic connections of the Central Amygdala
The central amygdala has only a few very minor projections to other amygdaloid 
nuclei, including the BLA, the anterior cortical nucleus the anterior amygdaloid area 
and the amygdalohippocampal area (Amaral et al., 1992; Jolkkonen & Pitkanen, 
1998). It has extensive intra- and interdivisional connections within however, as 
well as connections to regions included in the CEA -  BNST and SI (Grove, 1988; 
Sun et al., 1991).
The CeLc projects mainly within itself but also to the CeM. Projection to the core 
region of the lateral division (CeL) is light. The CeL also projects mainly within 
itself, but also to the CeLc and to the CeM. The Cel and CeM also have heavy 
intradivisional projections, but in addition the CeM projects to the CeLc (Jolkkonen 
& Pitkanen, 1998).
1.5.5. Connections with the ICM cells
The intercalated cell masses dispersed in tightly packed islets in the fibre tracts 
between the main amygdaloid nuclei provide a relay from input cells in the 
basolateral group to the output group of the Ce (Alheid et al., 1995; Pare & Smith, 
1993; Royer et a l , 1999). These GABAergic cells have been been shown to receive 
excitatory inputs from the basolateral nuclei (Royer et al., 1999) and to project into 
the CeM and CeL (Pare & Smith, 1993; Royer et al., 1999).
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1.6. PROJECTIONS FROM THE AMYGDALA
While it now accepted that the central nucleus acts as the primary output station for 
the amygdala (Pitkänen et al., 1997; Royer et al., 1999) projecting onto brainstem 
and hypothalamic regions critical for endocrine and autonomic control of 
homeostasis, the basolateral amygdaloid complex has also been found to project out 
of the amygdala. These outputs from LA and BLA include reciprocal connections 
back to corticies (Bacon et al., 1996; Saper, 1982) and the thalamus (Krettek & 
Price, 1977) and unidirectional projections to substantia innominata, ventral caudate 
putamen, nucleus accumbens, lateral bed nucleus of the stria terminalis, olfactory 
tubercle, premammillary nucleus and ventromedial hypothalamic nucleus (Krettek 
& Price, 1978).
Hypothalamic and brainstem targets of CEA projection neurones include lateral 
hypothalamus, paraventricular nucleus, dorsal motor nucleus of vagus, nucleus 
ambiguus, parabrachial nucleus, ventral tegmental area, locus coeruleus, dorsal 
lateral tegmental nucleus, pontine reticular formation, the central grey, and 
trigeminal facial motor nucleus (Beitz, 1982; Davis et al., 1994; Jackson & 
Crossman, 1981; Jongen-Relo & Amaral, 1998; Krettek & Price, 1978; Prewitt & 
Herman, 1998; Rizvi et al., 1991; Schwaber et al., 1980; Schwaber et al., 1982; 
Takeuchi et al., 1983; Zahm et al., 1999).
1.7. THE CENTRAL EXTENDED AMYGDALA: AN 
INHIBITORY INTERFACE
As well as sharing and efferent fibre targets in the brainstem and hypothalamus 
(Beitz, 1982; Jackson & Crossman, 1981; Moga et al., 1989; Schwaber et al., 1980; 
Schwaber et al., 1982; Weller & Smith, 1982), each CEA region (Ce, IS and BNST) 
also receives reciprocal connections from these regions (Bernard et al., 1993;
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Canteras et al., 1994; Grove, 1988, Halsell, 1992; Krukoff et al., 1993; Ottersen, 
1980; Sofroniew, 1983; Swanson et al., 1984; Vertes et al., 1995). The BLA and 
some cortical areas also provide input to all three regions of CEA (Grove, 1988; 
Saper, 1982). The projection from the basolateral amygdaloid nuclei to the Ce has 
been shown to provide excitatory input, as well as feedforward inhibitory input via 
the ICM (Pare & Smith, 1993; Royer et al., 1999), whereas the primary target of the 
cortical afferents has also been demonstrated to be the GABAergic interneurones in 
the Ce (Sun et al., 1994). The primary target of the aforementioned ascending inputs 
to the CEA is also thought to be these intrinsically projecting GABAergic neurones 
(Sun et al., 1994). These locally projecting neurones form extensive intrinsic 
interconnections between the Ce, BNST and SI (Grove, 1988; Sun et al., 1991; 
Weller & Smith, 1982). This has led to the proposal that an inhibitory interface gates 
the information flow between cortical and BLA afferents and the brainstem 
projection neurones in the CEA (Sun et al., 1994).
Under the scheme proposed by Sun et al (1994), the projection neurones of the CEA 
are under constant inhibitory control from activation of local GABAergic 
connections. On the afferent side, these inputs perform an integrating role for 
information passing into the CEA (Royer et al., 1999), whereas on the efferent side 
the reciprocal projections back to the CEA provide a master switch to rapidly 
disinhibit the projection neurones (through inhibitory inputs onto the GABAergic 
cells of the inhibitory network) (Sun et al., 1994). This master switch (as noted by 
Sun et al (1994) would be a rapid means for activating short stimulus unconditioned 
startle responses.
While the concept of the central extended amygdala is now widely accepted (Cassell 
et al., 1999), the interactions between the Ce, BNST and SI is not well understood. 
The Ce, BNST and SI have been shown to have similar efferent targets and to 
receive similar input and each region is able to effect behavioural (eg startle 
responses (Hitchcock & Davis, 1991; Walker & Davis, 1997)) and autonomic 
pathways (eg. cardiovascular regulation (Gelsema et al., 1993; Gelsema et al., 
1987)). However, the respective roles of each region in mediating these responses is 
unclear. Recently it has been proposed that regions within the CEA mediate 
different aspects of behavioural and automonic responses (Davis & Shi, 1999).
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Under this proposal the BNST and the Ce may have similar effects on behavioural 
and autonomic systems but are activated under different afferent circumstances. 
Evidence supporting this has come from lesioning studies showing that fear 
potentiated startle can be blocked by lesioning the Ce, whereas light enhanced 
startle is not. Alternatively, lesions of the BNST can block the light enhanced startle 
reflex but have little effect on fear potentiated startle (Walker & Davis, 1997). 
Lesions of the basolateral amygdaloid complex blocked both fear-potentiated and 
light enhanced startle, indicating that the output each region was dependant on some 
basolateral input.
1.8. THE SYNAPTIC PHYSIOLOGY OF THE CENTRAL 
AMYGDALA
In contrast to other regions of the brain (hippocampus, cortex), the circuitry of the 
amygdala has not been well established. Despite the work of numerous anatomists 
showing afferent, intrinsic and efferent connectional data, histochemical and 
cytoarchitectonic studies of cellular morphology, the nature of the synaptic 
transmission between the limbic structures has yet to be fully explored. The 
amygdala is often divided into a cortical-like input side and a striatum-like output 
side. To date, electrophyisological studies (with only eight exceptions) have 
examined the physiology of synaptic connections in the cortical-like areas of the 
basolateral complex and the associated cortices. Some understanding of the synaptic 
physiology of these regions, have led to the proposals that this area may be the site 
of some plasticity involved in the behavioural functions of the amygdala (Faneslow 
& LeDoux, 1999; Rogan & LeDoux, 1996).
The emergent picture of the central extended amygdala is also of a site capable of 
some processing involved with behavioural function. The innervation of this region 
by cortical afferents, and potential of the intrinsic GABAergic inhibitory network to 
modulate the ouput of this structure suggest that it too may perform an integrative
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role in amygdaloid function (Royer et al., 1999; Sun & Cassell, 1993; Sun et al., 
1991; Sun et al., 1994). The few studies which have examined the synaptic inputs 
onto central amygdaloid cells have until recently (Martina et al., 1999; Royer et al., 
1999), been done using sharp electrode techniques and have not discriminated 
between the subdivisions of the Ce despite reported connectional and 
cytoarchitectonic differences between these regions. The work contained in this 
thesis attempts to characterise the synaptic currents underlying the EPSP and IPSP 
in Central Amygdala, using established pharmacological criteria. To do so we have 
employed the blind whole cell patch clamp technique and recorded from neurones 
held in voltage clamp mode. The research in this thesis and that being performed in 
Denis Pare’s laboratory in Canada, are the first attempts at whole cell recording 
from neurones of the central amygdala.
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2. METHODS
2.1. PREPARATION OF BRAIN SLICES
Wistar rats 17-28 days old were anaesthetised with intraperitoneal pentobarbitone 
(50 mg/Kg body weight) and decapitated just prior to death according to 
institutional animal ethics committee guidelines.
The scull was exposed, cut along the midline, and removed using 14 mm rongeurs. 
The exposed brain was then removed, blocked coronally and glued onto the 
vibratome or microslicer cutting block and immersed in ice cold ACSF. The brain 
was then hemisectioned, and coronal slices (400 p.m thick) cut through the entire 
rostrocaudal extent. Slices were removed immediately, transferred to an oxygenated 
slice chamber containing ACSF at 30°C, and allowed to recover for 30 mins prior to 
recording. Slices were maintained at room temperature in oxygenated ACSF (In 
mM: NaCl 118, KC1 2.5, NaHC03 25, glucose 10, NaH2P04 1.2, MgCl2 1.3, CaCl2 
2.5) for several hours.
2.2. RECORDING CONDITIONS
Slices were placed in a perspex perfusion chamber of with bath volume of 1 ml, 
retained under a nylon stranded net, and superfused at 200 ml per hour with 
oxygenated ACSF at room temperature. Slices were visualised using a stereo 
dissection microscope (ISSCO) under translumination.
Whole cell recordings were made using 3-5 borosilicate glass electrodes using 
the blind approach (Blanton et al., 1989). Internal solutions used included potassium 
methyl sulfate (KmeS0 4 ) internal (in mM: KmeS0 4  135, NaCl 8, HEPES 10,
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MgATP 2, NaGTP 0.3, EGT A 0.2, osmolarity :280-290 mOsM, pH 7.3 with KOH), 
cesium chloride (CsCl) internal (in mM: CsCl 130, MgC^-öHiO 1, EGTA 10, 
HEPES 10, MgATP 2, NaGTP 0.2, osmoiarity 280-290 mOsM, pH 7.3 with CsOH) 
and cesium gluconate (CsGluc) internal (in mM: gluconate 107.5, CsCl 17.5, NaCl 
8, HEPES 10, MgATP 2, NaGTP 0.2, BAPTA 10, osmolarity: 280-290 mOsM, pH 
7.3 with CsOH). Membrane potentials recorded using the Cs Glue internal were 
corrected for a junction potential of + 17 mV. Recordings were made in both current 
clamp and voltage clamp configurations, and series resistance (10 - 30 MQ) 
monitored throughout the experiment. No series resistance compensation was used 
and experiments were rejected if series resistance changed by more than 10%.
Synaptic responses were evoked electrically using stainless steel bipolar stimulating 
electrodes (Frederick Haer) connected to Digitimer model DS2A stimulator boxes. 
Stimuli were 1-40 V in amplitude and 50 jis in duration.
Iontophoretic applications were made using borosilicate glass pipettes (>5 MQ) 
filled with acidic solutions. Negative retention currents (50-100 nA) and positive 
ejection current (100-200 nA, 0.1-1 s duration) were generated by a Dagan 6400 
iontophoresis unit. GABA and glycine solutions used were 300 mM (adjusted to pH 
3 with HC1).
Hypertonic sucrose (500 mM in ACSF) was applied by pressure injection through a 
borosilicate glass pipette (3-5 MQ). Blind application was made by sustained 
pressure injection with the pipette placed on the surface of the slice. Localised 
applications using IR/DIC techniques were made by brief low pressure applications.
2.3. DATA COLLECTION, ANALYSIS AND STATISTICS
Signals were filtered (5 kHz) and amplified using either an Axopatch ID or an 
Axopatch 200B amplifier (Axon instruments), digitised at 10 kHz using an ITC-16
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analogue to digital converter (Instrutech), and recorded on an Apple Macintosh 
computer (PowerMac or G3) or onto video tape using a Vetter PCM recorder (model 
200, A.C. Vetter Co.). Computer data acquisition was facilitated by Igor Pro 
software or by Axograph 4.0 software (Axon instruments). All data analysis was 
performed using Axograph 4.0 software. Results were compiled and analysed using 
Microsoft Excel. All values shown are mean ± SEM, and statistical comparisons 
were done using student’s t test.
2.4. DRUGS USED
Kynurenic acid (Sigma, RBI research chemicals); used at 2 mM, (1 M stock).
CNQX (Tocris Cookson); used at 10 pM, (10 mM stock). 
d-APV (RBI research chemicals); used at 30 pM, (30 mM stock).
Bicuculiine methiodide (Sigma, RBI research chemicals); used at 10 pM (except 
where otherwise stated), (10 mM stock).
Picrotoxin (Sigma); used at 100 pM (except where otherwise stated), (100 mM 
stock).
SR95531 (Sigma); used at 2 pM (except where otherwise stated), (1 mM stock). 
TPMPA (RBI research chemicals); used at 60 - 100 pM (except where otherwise 
stated), (100 mM stock).
Strychnine (Sigma); used at 1 pM (except where otherwise stated), (10 mM stock). 
Tetrodotoxin (Alamone); used at 0.5 pM, (1 mM stock).
Propofol (RBI research chemicals); used at 10 pM, (10 mM stock).
Pentobarbitone (Bomac Laboratories); used at 25 pM, (25 mM stock).
Diazepam (gift from Professor P. Gage) ;used at I or 10 pM, (10 mM stock). 
Flurazepam (gift from Professor G.A.R. Johnston); used at 1 pM, (1 mM stock).
Ro 15-1788 (gift from Professor G.A.R. Johnston); used at 1 pM, (1 mM stock).
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3. MEMBRANE PROPERTIES AND SYNAPTIC 
CURRENTS OF Ce NEURONES
3.1. INTRODUCTION
Of seven publications showing intracellular electrophysiological recordings made 
from central amygdala neurones, three have recorded in rat brain slices (Nose et al., 
1991; Rainnie et al., 1992; Schiess et al., 1993), three in guinea pig brain slices 
(Martina et al., 1999; Nose et al., 1991; Royer et al., 1999) and two in dissociated 
neurones (Yu & Shinnick-Gallagher, 1998; Yu & Shinnick-Gallagher, 1997).
The first of these papers by Nose et al examined electrically evoked post synaptic 
potentials (PSPs) in the whole of the Ce nucleus (and the results shown are all 
recordings from guinea pig). This paper reported excitatory PSPs (EPSPs) elicited 
by stimulating in the BLA and inhibitory PSPs (IPSPs) when stimulating in the 
dorsal region of the lateral division of the Ce. The EPSPs were shown to be 
mediated by the AMPA and NMDA glutamate receptors, and by nicotinic receptors 
sensitive to d-tubocurarine and hexamethonium. The IPSC was blocked by the 
GABAa antagonist bicuculline and the glycine receptor antagonist strychnine, 
suggesting both GABAergic and glycinergic inhibition.
Rainnie et al examined the effects of corticotrophin releasing factor on Ce neurones 
in a paper published in 1992 (Rainnie et al., 1992). This paper showed some passive 
membrane properties, the afterhyperpolarisation (AHP) and a hyperpolarising effect 
of corticotrophin releasing hormone on some Ce neurones which reduced the slow 
AHP in these neurones. The same group published another paper in 1993 (Schiess et 
al., 1993) that was concerned with the firing properties and AHPs of Ce neurones. 
This paper sought to classify the Ce neurones according to these properties.
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Other than the most recent papers (Martina et al., 1999; Royer et al., 1999) previous 
studies have examined the properties of the neurones of the whole Ce nucleus, 
without reporting or discussing subdivisional differences. As these recent papers, 
and complimentary anatomical studies have shown, the divisions of the Ce represent 
distinct regions of connectivity (Pitkänen et al., 1997) and include neurones of 
distinct cytological properties (McDonald, 1982).
In contrast to the earlier Sheiss et al study (Schiess et al., 1993), Martina et al 
reported nine distinct neuronal subtypes in the lateral and medial divisions of Ce 
based on membrane properties and firing patterns (Martina et al., 1999). This study 
also described the morphology of CeL and CeM neurones. Notably, differences 
were observed both between the cells of each division, although different classes of 
cells within the CeL appeared to have similar cellular morphology. The same group 
more recently published a study examining the synaptic responses of neurones in 
CeL and CeM (Royer et al., 1999). This study indicated that CeL neurones 
responded to electrical stimulation in the LA and BLA, whereas CeM neurones 
responded to BLA and BMA stimulation. This paper also showed that IPSPs 
recorded in CeM neurones in response to stimulation of the nuclei of the basolateral 
complex nuclei, arrive via a feed forward inhibitory pathway involving a network of 
interconnected ICM cells located between the basolateral nuclei and the central 
nucleus. These papers suggest a far more complex scenario for the circuitry and 
cellular properties of the Ce than reported previously by Scheiss et al and Nose et 
al.
This chapter shows the first whole cell recordings made from Ce neurones in rat. 
The objective of this chapter is to examine membrane and firing properties of rat Ce 
neurones and the synaptic currents of the neurones generated by stimulation within 
the basolateral complex nuclei.
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3.2. RESULTS
3.2.1. Recordings from CeL neurones
CeL neurones were held in current clamp mode at Vm -60 (using potassium methyl 
sulfate (KmeS0 4 ) based internal solution) and the responses to 600 ms current 
injections from -300 pA to 500 pA, recorded. Six neurones were held in current 
clamp and a series of increasing current steps from -300 pA to +400 pA were 
recorded. Three neurones showed firing patterns featuring delayed firing (Figure
3.1. A), two fired just one or two spikes rapidly and then stopped firing completely 
(Figure 3.1.B), and one neurone fired repetitively over the entire length of the 
current step (Figure 3.1.C).
All three firing patterns recorded, correspond to neurone types seen in guinea pig by 
Martina et al (Martina et al., 1999). The first group of neurones (delayed firing 
neurones) appear similar to the late firing neurones reported in guinea pig CeL and 
were similarly the most frequently encountered. The rapidly spiking neurones which 
fired single spikes probably correspond to the fast-spiking neurones of the guinea 
pig CeL, although the CeL neurones do not fire repeatedly like the guinea pig cells. 
Repetitive firing neurones were also encountered in the guinea pig CeL.
3.2.2. Recordings from CeM neurones
Using a similar protocol as used previously for CeL neurones, the firing patterns of 
CeM neurones could be classified into two classes. The most prominent class (6 of 9 
CeM neurones recorded) were delayed firing neurones (Figure 3.2.A). The 
remaining neurones were all rapid firing neurones which displayed a characteristic 
spike on the off phase of the current injection (Figure 3.2.B).
As for the CeL, the neurones recorded in CeM corresponded to classes of neurones 
reported by Martina et al in the guinea pig (Martina et al., 1995). Late firing 
neurones were the most prominent firing class in both species and both had a class
30 mV
200 ms
200 ms
30 mV 
500 pA
30 mV
200 ms
Figure 3.1. Firing patterns of CeL neurones in response to current 
injections.
A. Delayed firing neurone, B. single firing neurone and C. repetitive firing 
neurone. Neurones were held at Vm -60 mV, and responses to increasing 
current injections (-300 pA to 500 pA in 50 pA increments) were recorded.
30 mV
200 ms
20 mV
200 ms
Figure 3.2. Firing patterns of CeM neurones in response to current 
injections.
A. Rapidly accomodating neurone (with spike on the off phase of the 
current injection), and B. late firing neurone. Neurones were held at Vm 
-60 mV, and response to increasing current injections (from -200 pA to 
300 pA in 50 pA increments) were recorded.
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of fast spiking neurones. The rat fast spiking cells again showed only single spikes, 
whereas the guinea pig fast spiking cells had spiked repeatedly.
3.2.3. Synaptic responses of Ce neurones
Recording in voltage clamp mode, synaptic responses to electrical stimulation of the 
three basolateral nuclei were recorded from 43 CeL and 19 CeM neurones, using 
KmeSCU or cesium gluconate (CsGluc) based internal solutions. The chloride 
reversal potential for these internal solutions (-60 and -50 mV respectively) allowed 
us to record at subthreshold potentials (Vm -40), the inhibitory post synaptic current 
(IPSC) mediated by the fast ionotropic GABA or glycine receptors, as an outward 
current (an influx of anionic chloride). The excitatory post synaptic current response 
(EPSC) appeared as inward currents (cationic sodium and potassium influx) at the 
reversal potential for chloride.
Synaptic responses were recorded for electrical stimulation of LA, BLA, and the 
dorsal region of CeL itself (n = 25, 26 and 14 respectively). Control recordings from 
these regions produced an inward/outward current pair (EPSC/IPSC) at Vm -40 and 
inward currents (EPSC) at the chloride reversal potential (Figure 3.3.).
Stimulation of the BLA and LA produced no synaptic response in CeM neurones in 
contrast (n= 6 and 5 respectively) but synaptic responses were elicited by 
stimulating the BMA (n = 10) and the CeL (n = 15) (Figure 3.4.). These responses 
also consisted of EPSC/IPSC responses recording at membrane potential of -40 mV, 
and an EPSC only at the chloride equilibrium potential.
3.2.4. Inhibitory inputs from LA and BLA to CeL are disynaptic
The IPSC recorded in CeL neurones in response to stimulation in the LA and BLA 
was blocked by the application of the glutamate receptor blocker kynurenic acid (2 
mM) (n = 4, Figure 3.5.A). This indicates that the IPSC recorded in CeL stimulating 
these regions results from the firing of a second neurone between the LA and BLA,
A BMA input
Vm -40
100 pA
Vm -60
B  CeL input
Vm -40
Vm -60 50 ms
Figure 3.3. Synaptic responses in CeM neurones.
Averages of 10 synaptic responses recorded at Vm -40 and -60 when 
stimulating electrically in BMA. (A) and CeL (B). The internal solution 
used was KmeS04 based, with reversal potential for chloride at Vm -60
mV.
A  LA input
Vm -40
200 pA
B  BLA input
25 ms
Vm -40
Vm -60
Figure 3.4. Synaptic responses in CeL neurones.
Averages of 6 synaptic responses recorded at Vm -40 and -60 when 
stimulating electrically in LA. (A) and BLA (B). The internal solution used 
was KmeS04 based, with the reversal potential for chloride at Vm -60 mV.
A BLA input LA input
ICM input
100 ms
Figure 3.5. Disynaptic and monosynaptic inhibitory inputs to CeL 
neurones.
A. IPSC evoked by electrical stimulation in the BLA and LA in control 
and blocked (heavy line) after application of kynurenic acid (2 mM). B. 
IPSC evoked by stimulation in the ICM area between LA and Ce, in 
control (light line) and in kynurenic acid (heavy line). All recordings were 
made at Vm 0 using cesium gluconate based internal solution (corrected 
for -17 mV junction potential).
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and the CeL. Moving the stimulators onto the edge of the CeL -  in the vicinity of 
the ICM cells in the internal capsule, an IPSC was elicited which was not blocked 
by kynurenic acid (Figure 3.5.B). Similarly, the IPSC recorded when stimulating in 
the CeL itself was not blocked by kynurenic acid.
An IPSC was recorded in CeM in the presence of kynurenic acid when stimulating 
in CeL and the BMA (n = 6 and 4 respectively), indicating direct GABAergic 
projections.
3.2.5. Excitatory Currents of Ce neurones
The Ce EPSC could be isolated in the presence of the GABA/Glycine receptor 
antagonist picrotoxin. Recording in either CeL or CeM using CsGluc based internal, 
the EPSC was a fast rising and decaying inward current at negative membrane 
potentials, and a fast rising and slow decaying outward current at positive membrane 
potentials. Recording these responses at a range of membrane potentials from -100 
mV to +40 mV (Figure 3.6.A), the amplitude of the response at the peak of the 
inward current plotted against the membrane potential resulted in a linear I/V 
relationship passing through Vm 0 (Figure 4.6.B open). This voltage insensitive I/V 
relationship and the fast kinetics of the inward current recorded at hyperpoiarised 
membrane potential is typical of excitatory currents mediated by AMPA type 
glutamate receptors (Hestrin et al., 1990). The amplitude of the slow decaying 
outward current (measured at 140 ms post stimulus) similarly plotted against 
membrane potential (Figure 3.6.B filled), resulted in a voltage dependant I/V 
relationship typical of NMDA receptor mediated currents, with a region of negative 
slope between membrane potentials -70 and -30 mV (Hestrin et al., 1990). 
Confirming this, the slow decaying component was blocked by the specific NMDA 
antagonist D-APV (30 jiM) leaving just the fast rising and decaying component 
(Figure 3.6.C). This component was blocked by the specific AMPA receptor 
antagonist CNQX (10 |iM) (Figure 3.6.D), confirming that this component of the 
EPSC was an AMPA receptor mediated current.
A  Control
Vm (mV) 
-100 *
- 200-
C d-APV -400J Current (pA)
200 pA
100 msd-APV, CNQX
Figure 3.6. Excitatory currents in Ce neurones are mediated by AMP A 
and NMD A receptors.
A. Control recordings of EPSCs (in 100 pM picrotoxin) at membrane 
potential -97 to +43 mV* using cesium gluconate based internal. B. The 
amplitude of these responses at 10 ms and 140 ms post stimulus (indicated 
by open and closed circles respectively) plotted against the membrane 
potential. C. EPSCs recorded at membrane potential -97 to +43*, in the 
presence of extracellular d-APV (30 pM) and D. after addition of CNQX 
(10 pM). *Membrane potentials corrected for -17 mV junction potential.
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3.2.6. Monosynaptic IPSC are chloride currents
Recording in the presence of 2 mM kynurenic acid, a monosynaptic IPSC was 
elicited by stimulating in the ICM region immediately lateral to the CeL. This IPSC 
was recorded at membrane potentials from -100 mV to 0 mV using CsGluc based 
internal solution (Figure 3.7.A), and -80 to +40 mV using cesium chloride internal 
(CsCl). These currents reversed at the chloride equilibrium potential for either 
internal solutions (-52 mV and 0 mV respectively) as shown on the average 
normalised I/V relationship (Figure 3.7.B) (n = 4 for CsGluc, n = 2 for CsCl).
Application of the GABAa antagonist bicuculline to the external solution resulted in 
a reduction of the IPSC amplitude, indicating that GABAa receptors were 
contributing to the IPSC. The Residual IPSC was also found to reverse at the 
chloride reversal potential for the CsCl and CsGluc internals used (Figure 3.7.C,D), 
indicating that this IPSC was also mediated by a chloride conductance.
3.3. DISCUSSION
Although the sample of neurones recorded was small, the proportion of cell types of 
similar firing types as those previously shown in guinea pig was consistent with the 
proportions of these types in that species [Martina, 1999 #2048], Biocytin labeling 
of the Ce neurones was not successful, so no correlation of these firing properties 
could be made with cell morphology. Filling neurones with lucifer yellow was also 
unsuccessful as no filled cells were seen in the slice when examined under UV light 
immediately after removal of the recording pipette. It is likely that the cells recorded 
from were removed from the slice on withdrawal of the recording pipette, possibly 
as a result of the small size of Ce neurones and the recording conditions.
The firing patterns exhibited by the majority of Ce were either rapidly accomodating 
(firing a single spike at the onset of the current injection) or delayed firing (firing at 
the middle). These firing patterns are most likely influenced or a result of the
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presence of voltage gated potassium channels on the soma or dendrites of the cells, 
and the activation and deactivation kinetics of these channels. It is possible that 
recording from soma verses dendritic locations may influence the firing pattern in 
response to a current injection if for example the potassium channels are 
differentially localised to soma or dendrites and were more or less activated in 
response to the current injection at one point verses the other. However, it was 
unlikely that recordings were made from dendrites locales as these experiments 
were carried out using recording pipettes of approximately 3Mohm resistance and 
the dendrites of these cells are very thin. Thus the most likely explanation for the 
different firing patterns found is a distribution of cell types in each location or 
different voltage gated potassium channel phenotypes.
The synaptic responsiveness to stimulation in the various basolateral nuclei was also 
similar to that shown for guinea pig [Royer, 1999 #1964], with the exception that in 
this study no synaptic responses were elicited in CeM when stimulating in the BLA. 
The CeL was found to receive excitatory and disynaptic inhibitory input from 
stimulation in the LA and BLA, whereas the CeM received direct inhibitory and 
excitatory input from stimulation in the BMA region and the CeL.
The use of the bipolar recording stimulators as in this study does not distinguish 
between inputs that are situated in the area of stimulation and axons that pass 
through this region (fibres of passage). For instance, while axonal tracing studies 
have shown that LA does project to the CeL [Smith, 1994 #1922], fibres from the 
cortical input to the CeL may also pass through the LA region (A Pitkannen 
personal communications, 1999). Thus though it is likely that the EPSC in CeL 
stimulated in LA results from activation of LA neurones it is possible that cortical 
afferents passing through the LA region stimulated may contribute to the responses 
recorded. Furthermore, the disynaptic IPSC recorded in the CeL when stimulating in 
the LA may also result from cortical or LA innervation of these GABAergic inputs. 
Also, despite the fact that the proximity of the stimulation site for eliciting the 
momosynaptic IPSC in the CeL is suggestive of excitation of neurones in the ICM 
or CeL itself, and these regions have both been shown to innervate Ce neurones 
[Jolkkonen, 1998 #1965; Royer, 1999 #1964], there is also the possibility that 
another nucleus provides this inhibition and the axons from this region pass through
Figure 3.7. Monosynaptic inhibitory currents in CeL are chloride currents. 
A. IPSCs recorded in a CeL neurone in the presence of kynurenic acid (2 
mM), at membrane potentials of -97, -77, -57, -37, -17 and +3 using 
cesium gluconate internal solution. B. Normalised I/V relationship for 
IPSCs recorded using cesium gluconate internal (filled circles) and cesium 
chloride internal (open squares). Reversal potentials were -52 and 0 mV 
respectively. C. IPSC in the presence of bicuculline (10 pM), recorded at 
Vm -97 to +3 mV, using cesium gluconate internal solution. D. average 
normalised I/V relationship for similar IPSC recorded using cesium 
gluconate (filled circles) and cesium chloride (open squares) internal 
solutions. Reversal potentials were -44 and 0 mV respectively. Membrane 
potentials have been corrected for -17 and 10 mV junction potentials for 
cesium gluconate and cesium chloride internals respectively.
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this ICM region. While these results do not resolve the complex circuitry projecting 
to the Ce, they do reflect the possibilities for innervation provided by tracing studies 
of the extrinsic connections of the Ce.
The pharmacology of the excitatory and inhibitory currents recorded in CeL and 
CeM showed some similarity to that previously reported. Nose et al identified the 
receptors underlying the EPSP as the NMDA and non-NMDA type glutamate 
receptors by blocking with the respective antagonists D-APV and CNQX [Nose, 
1991 #1996]. The same group also described an EPSP that was sensitive to d- 
tubocurarie and hexamethonium, and an IPSP not blocked by bicuculline but 
blocked by strychnine. The current underlying the putative nicotinic EPSP was not 
found in neurones when recording with KmeS0 4  internal, however the block of the 
IPSC by bicuculline (10 pM) was not complete, confirming the presence of an 
additional inhibitory' mechanism.
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4. INHIBITORY SYNAPSES ON CE NEURONES
In the previous chapter, the inhibitory post synaptic currents of CeL neurones were 
found to be chloride currents mediated by receptors partially blocked by low 
concentrations of bicuculline. This chapter investigates the type of ionotropic receptor 
mediating the IPSC in CeL neurones and the pharmacology of these receptors.
4.1. GABA
The debate as to whether nervous transmission was chemical or electrical had raged 
since the 1930’s, but as new physiological techniques using micropipettes became 
available in the 1950’s, transmission had been shown to be chemical (Brock et al., 
1952) and the mechanisms underlying the EPSP’s and IPSP’s were beginning to be 
understood (Coombs et al., 1955; Coombs et al., 1955; Coombs et al., 1955; Eccles, 
1964). Research by Paul Fatt and Bernard Katz in the early 50s had established 
acetylcholine as a putative chemical transmitter mediating nerve to muscle 
transmission, however the nature of the chemical transmitters in other regions had 
not been established. In 1956 Bazemore et al identified the amino acid y- 
aminobutyric acid (GABA) as the principle component of the inhibitory chemical 
transmitter which had been called Factor I (Bazemore et al., 1956). A number of 
reports then appeared in rapid succession from 1957 to 1959 showing depressant 
effects of the amino acid y-aminobutyric acid (GABA) in various nervous tissue 
preparations (Curtis et al., 1959; Edwards & Kuffler, 1959; Edwards & Kuffler, 
1957; Eidelberg & Feldman, 1958; Enger & Burgen, 1957; Iwama & Jasper, 1957; 
Marrazi et al., 1958; Purpura et al., 1957; Sigg & Grundfest, 1958). David Curtis, 
working in laboratories in this institute, was examining the effects of what he termed 
excitant and depressant amino acids on isolated spinal cords. This research 
demonstrated that both GABA and glycine produced neuronal membrane
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hyperpolarisations consistent with those described in the analysis of the IPSC by 
Eccles et al (Coombs et al., 1955; Curtis et al., 1961). GABA was subsequently 
shown to be localised to mammalian nerve terminals (Neal & Iversen, 1969), from 
where it is released in a calcium-dependant manner in response to depolarising 
stimuli (Bradford, 1970).
GABA is now accepted as the major inhibitory transmitter in the mammalian CNS 
(Nicoll et al., 1989). Its actions can be divided into fast ionotropic receptor mediated 
inhibition which produces a rapid and acute inhibitory hyperpolarisation (Costa, 
1998; Mody et al., 1994), prolonged metabotropic inhibitory hyperpolarisation 
which may modulate spontaneous activity (Mott & Lewis, 1994), and presynaptic 
metabotropic inhibition of release (Ault & Nadler, 1982; Blaxter & Carlen, 1985; 
Lanthorn & Cotman, 1981).
4.2. GABA RECEPTORS
GABA receptors have been classified into ionotropic types (GABAa receptors and 
GABAc receptors) and a metabotropic type (GABAb). The ionotropic receptors gate 
chloride channels formed through the structure of the receptor complex. The 
metabotropic GABAb receptor is linked via transduction proteins called G proteins 
to effector potassium ion channels and other intracellular processes (Mott & Lewis, 
1994).
4.2.1. GABAa Receptors
GABAa receptors were originally designated as those GABA receptors which are 
GABA-gated chloride channels blocked by the competitive antagonist bicuculline 
(Hill & Bowery, 1981). They have been localised to the synaptic specialisation and 
extra-synaptically (Nusser et al., 1998), and both pre- and post-synaptically 
(Johnston. 1996).
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Structurally, GABAa receptors are thought to be pentameric combinations of 
GABAa subunits (by analogy with the nicotinic receptor - (Unwin, 1989)), and 
recent electron microscopy appears to support this (Nayeem et al., 1994). Since the 
first reported cloning of GABAa subunits (a l and ßl by Schofield et al (Schofield et 
al., 1987), the GABAa subunit family has grown to include 19 related subunits 
(table 5.1.). This number is further increased by alternate splicing in at least 5 of 
these subunits (Barnard et al., 1998). It is thought that these subunits do not 
randomly combine to form pentamers however. Studies to date indicate that the 
GABAa receptors of the CNS are combinations of a  and ß subunits with one or 
more y, 5 or 8 subunits. The n subunit has only been detected in peripheral tissue, 
though is has been demonstrated to be able to form functional GABA receptors with 
a  and ß subunits in expression systems (Hedblom & Kirkness, 1997).
The consequence of such a large number of subunit combinations is a heterogenic 
population of GABA receptors with similarly heterogenic channel properties and 
pharmacological properties. Furthermore, the presence of several subunit 
combinations forming different functional GABAa receptors within the same cell 
and at specific synapses within that cell (Nusser et al., 1996; Nusser et al., 1998) 
adds yet another level of complexity to GABAa mediated inhibition.
4.2.1. GABAr receptors
The lipophilic GABA analogue baclofen was found to activate a class of GABA 
receptors which was insensitive to bicuculline (Curtis et al., 1974). These receptors 
were described as GAB Ab receptors by Hill and Bowery (1981) who found that 
these receptors (activated by both GABA and baclofen) depressed noradrenaline 
release from autonomic nerve terminals in a bicuculline insensitive manner.
Postsynaptic GABAb mediated inhibition has been shown to be mediated by 
potassium conductances, which are recorded as slow IPSCs under whole cell voltage 
clamp. Rise times of these currents are in the order of tens of milliseconds and decay
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times in the order of hundreds of milliseconds (Ling & Bernardo, 1994; Ulrich & 
Huguenard, 1996). The resultant slow inhibitory potentials mediated by GABAb 
receptors is prolonged and may last for several seconds (Danober & Pape, 1998; 
Lambert & Wilson, 1994). Postsynaptic GABAb activation has also been shown to 
effect longer term changes in the post synaptic cell through negative regulation of 
transcription (Barthel et al., 1996), or modulation of other intracellular processes 
such as the synthesis of IP3 (Mott & Lewis, 1994).
Presynaptic GABAb inhibition has been demonstrated to occur at both excitatory 
(Ault & Nadler, 1982; Blaxter & Carlen, 1985; Lanthorn & Cotman, 1981) and 
inhibitory terminals (Davies et al., 1990; Misgeld et al., 1989). The mechanism of 
presynaptic GABAb inhibition has been the subject of some debate. The two 
potential mechanisms proposed are; 1) increasing potassium conductance which 
shunts the action potential at the terminal resulting in less activation of voltage 
sensitive calcium channels and hence less release and 2) direct negative modulation 
of the calcium channel via a G-protein linked to the GABAb receptor with the same 
ultimate effect (Mott & Lewis, 1994). Initially the potassium conductance 
mechanism was discounted as the presynaptic action of the specific GABAb agonist 
baclofen was not blocked by extracellular barium. Recently however, postsynaptic 
GABAb responses have been shown in the presence of extracellular barium 
(Yamada et al., 1999) reigniting the possibility of potassium mediated presynaptic 
inhibition. The calcium channel hypothesis has also been favoured by recent studies. 
Takahashi et al have recently shown GABAb mediated effects on presynaptic 
calcium influx and transmitter release (Takahashi et al., 1998). The mechanism of 
presynaptic GABAb inhibition thus remains controversial.
GABAb receptors are now known to be metabotropic GABA receptors formed as a 
dimer of two subunits - GABAbRI (which occurs in two splice variants: 
GABAßRla and GABABRlb) and GABAbR2 (Jones et al., 1998; Kaupmann et al., 
1998; Kuner et al., 1999; White et al., 1998). They are found both pre- and the post- 
synaptically (Bowery, 1993) and both synaptically and extrasynaptically (Pham et 
al., 1998). They are found in both peripheral and nervous tissue, and in the CNS 
they appear in varied density in most regions of the brain.
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4.2.3. GABAc receptors
A class of GABA receptors which was neither blocked by bicuculline nor activated 
by baclofen was first described by Drew et al (Drew et al., 1984). Following the 
definitions for GABA receptor types introduced by Hill and Bowery (Hill & 
Bowery, 1981), these receptors were not GABAa or GABAb receptors, and they 
subsequently have come to be called GABAc receptors. GABAc receptor mediated 
currents were first studied in isolation when bovine retinal cDNA was expressed in 
xenopus oocytes (Polenzani et al., 1991). Subsequently, they been shown in a 
variety of mammalian (Feigenspan et al., 1993) and non-mammalian retinal cell 
types (Dong et al., 1994; Lukasiewicz et al., 1994; Qian & Dowling, 1993; Qian & 
Dowling, 1994).
GABAc receptors are thought to be multimers of the p type GABA receptor 
subunits (table 5.2.). These subunits are expressed highly in retinal cells, and when 
expressed in xenopus oocytes, form functional homomeric and hetermeric p receptor 
GABA receptors which are insensitive to bicuculline (Shimada et al., 1992). These 
subunits form receptors with an integral chloride selective ion channel which opens 
in response to GABA or c/s-aminocrotonic acid (CACA) application (Johnston, 
1996). The distribution of the p subunits is not limited to the retina however, as all 
three p subunits have been found to be expressed outside the retina (Enz & Cutting, 
1999; Wegelius et al., 1998). The p subunits appear to combine only with selected 
non-p GABAa subunits to form functional receptor complexes (Ekema et al., 1998).
4.3. GABA RECEPTOR PHARMACOLOGY
The ionotropic GABA receptors are the target of a wide range of pharmacological 
agents. More than one hundred ligands have been found to bind to and activate, 
inhibit or modulate the GABAa receptor (Johnston, 1996). These agents can be 
divided into three classes- inhibitors (including competitive and non-competitive
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types), agonists, and allosteric modulators. The allosteric modulators exert their 
effects on the GABA receptor through alteration of the channel opening frequency 
(Orser et al., 1994; Rogers et al., 1994), or open time (Study & Barker, 1981; 
Twyman & Macdonald, 1992). These agents are also divided into broad categories, 
based on the chemical structure and binding site of the agent. Some of these include 
the benzodiazepines, barbiturates, volatile anesthetics and neuroactive steroids.
4.3.1. GABAa receptor antagonists
The alkaloid bicuculline was the first GABA receptor antagonist described (Curtis et 
al., 1970) and antagonism by bicuculline became one of the pharmacological criteria 
defining the GABAa class of receptor in 1981 (Hill & Bowery, 1981). Though it is 
now accepted that bicuculline acts by competing with agonist for the GABA binding 
site, the actual site of bicuculline interaction has not been resolved (Johnston, 1996). 
Other competitive antagonists including (in order of potency), RU5135, pitrazepin, 
SR95531 (gabazine), (+)-hydrastine, securinine, (+)-tubocurarine, and 
benzylpenicillin are thought to share some structural similarities and thus act at 
similar if not the same site as bicuculline (Rognan et al., 1992).
The non-competitve antagonists are thought to act at sites close to or within the 
chloride ion channel of the GABAa complex. Picrotoxin (an equimolar combination 
of picrotin and picrotoxinin) is the most widely used of these agents. Radiolabelled 
analogues of picrotoxinin indicate a binding site close to the chloride channel. 
Furthermore, binding of a number of other allosteric modulators and GABAa 
receptor agonists reduce the binding affinity of radiolabelled picrotoxin analogues 
(Johnston, 1996) and picrotoxinin can inhibit the GABAa receptor when 
administered intracellularly (Akaike et al., 1985). Other non-competitive antagonists 
include /-butylbicyclophosphorothionate (TBPS), m-benzenesulfonium diazonium 
chloride, 5-guanidinovaleric acid, cunaniol, sulfated dopamine metabolites, and 
furosemide.
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4.3.2. GABAb receptor antagonists
The search for specific potent inhibitors of GABAb receptors was hindered by the 
fact that no naturally occurring antagonists had been identified, and was thus 
directed towards synthetic analogues of GABA and the other known agonist, 
baclofen. The first recognised selective GABAb antagonist to emerge from this 
process was a phosphonic derivative of baclofen, 3-amino-2-(4-chlorophenyl)- 
propylphosphonic acid (phaclofen) (Kerr et al., 1987). Though specific for GABAb 
receptors, phaclofen is only effective at high concentrations (~1 mM (Mott & Lewis, 
1994)), though it does show slightly higher potency at post-synaptic GABAb sites 
over pre-synaptic (Dutar & Nicoll, 1988). More potent antagonists were found 
among the sulfonic analogues of baclofen, including saclofen and 2-hydroxy 
saclofen (Curtis et al., 1988; Kerr et al., 1988). These compounds were an order of 
magnitude more potent than phaclofen but high concentrations of the antagonists 
were still required to block agonist binding, and non-specific effects have been 
reported at these concentrations (al-Dahan et al., 1990).
The most potent antagonists reported to date have been phosphinic analogues of 
GABA. The first of these, CGP35348, was as potent as 2-hydroxysaclofen, but able 
to cross the blood-brain barrier (Kerr & Ong, 1995). This compound, like the other 
phosphinic acid derivatives subsequently reported has no reported non-specific 
affects at GAB Aa, glutamate, or a range of other receptors. The most potent of these 
derivatives, CGP 54626 and CGP 55845 are 5000 times more potent than 
CGP35348 and 15000 times more potent than phaclofen acting at nanomolar 
concentrations (Mott & Lewis, 1994).
4.3.3. GABAc receptor antagonists
Despite being insensitive to the classical GABAa antagonist bicuculline, GABAc 
receptors have been shown to be antagonised by other GABAa antagonists 
(SR95531) and agonists (3-aminopropanesulfonic acid (3-APS) and z-3- 
(amidinothio)propenonic acid (ZAPA)). Similarly, the classical GABAb agonist 
baclofen, and antagonists saclofen and phaclofen have no GABAc activity, whereas
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other G A B A b active compounds are quite potent antagonists (3- 
aminobutylphosphimc acic (3-APPA) and 3-aminopropyl(methyi)phosphinic acid 
(3-APMPA) (Woodward et al., 1993). The GABAb agonists 3-APPA and 3- 
APMPA in particular provided the lead for developing the first specific antagonist 
of GAB Ac receptors -  TPMPA (Ragozzino et al., 1996). This compound is a potent 
inhibitor of retinal GABAc receptor responses (Kb = 2 pM), and at least 100 times 
less active at GABA receptors and 500 times less active as an agonist of GABAb 
receptors (Murata et a l,  1996). Recently however, the sensitivity of GABAc 
comprising p2 subunits has been shown to be up to 8 times less than that for the 
homomeric pi GABAc receptors. The TMPMA sensitivity of GABAc receptors 
containing p3 subunits as homomers or heteromers with other p subunits, has not 
been studied.
4.3.4. Benzodiazepines
Benzodiazepines have been used therapeutically since the early 1960's as 
anxiolytics, anticonvulsants, sedative-hypnotics and muscle-relaxants (Dunn et al., 
1994). However, it wasn’t until the mid to late 1970’s that the action of these drugs 
was shown to be exerted through the potentiation of the inhibitory action of GABA 
(Costa et al., 1975; Haefely et al., 1975). Subsequent studies indicated this action 
was the result of these agents binding directly to a benzodiazepine binding site (BZ) 
integral to the GABA receptor complex (Olsen, 1981). The GABA/BZ receptor, as it 
then became known, was then classified according to the actions of an expanding 
range o f benzodiazepine site ligands into three types. The first type, BZj, 
demonstrate high affinity modulation by zolpidem, the triazolopyridazine 
CL218872, and some ß-carbolines. BZ2 receptors show low affinities for these 
agents, but high affinity for flunitrazepam. Finally, BZ3 type receptors are 
insensitive to the classical 1,4-benzodiazepine diazepam but sensitive to the negative 
allosteric modulator Rol5-4513.
With the cloning of the GABA receptor subunit family (Schofield et al., 1987), a 
molecular basis for the observed benzodiazepine sensitivities and efficacies emerged 
(Pritchett et al., 1989). Photoaffinity labeling (Duncalfe et al., 1996), mutation
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studies (Amin et al., 1997; Buhr et al., 1997; Buhr & Sigel, 1997; Wieland et al., 
1992) and subunit selective expression studies (Pritchett et al., 1989; Pritchett et al., 
1989) have indicated that a  and y subunits form the benzodiazepine binding site. 
The expression studies also demonstrated that it was the different a  and y subunit 
combinations that form this site which determined the specificity, potency and in 
some cases effect, of a particular benzodiazepine at a particular GABA receptor 
type. Receptors containing an a l  subunit in combination with a y2 subunit were 
found to exhibit BZ1 type affinity for CL218,872 (Hadingham et al., 1993; Pritchett 
et al., 1989) whereas receptors containing a2, a3 and a5 subunits are of the BZ2 
type, with lower affinity for CL218,872 (Wafford et al., 1992; Wieland et al., 1992). 
Receptors containing the a4 or a6 subunit fall into the BZ3 class, being insensitive 
to Diazepam, having low CL218,872 affinity but binding Ro 15-4513 (Wieland et 
al., 1992). The y subunit type present also influences the affinity of various 
benzodiazepines for the binding site. The yl subunit when expressed in combination 
with a  and ß subunits generally reduces the affinity of these receptors for most 
benzodiazepines compared to the same combinations containing a y2 subunit 
(Whiting et al., 1995). Furthermore, inverse agonists such as DMCM and Rol5- 
4513 have been shown to act as agonists at receptors containing the yl subunit (Puia 
et al., 1991). The y3 subunit also confers some lower sensitivities to some 
benzodiazepines (Herb et al., 1992) but the efficacy of these agents are similar for 
y2 and y3 containing receptors (Whiting et al., 1995). In the light of the fact that the 
recombinant receptor studies have revealed such an array of benzodiazepine 
affinities and efficacies, and that no clear typical BZ2 response or molecular 
combination has been found, the previous BZ 1-3 classification system and the 
terms benzodiazepine receptor and GABA/Benzodiazepine receptor are now 
considered outmoded (Barnard et al., 1998). Rather, it is now more pertinent to 
classify the benzodiazepine based on its affinity and effect at GABA receptors of 
particular subunit combinations.
Drugs acting at the benzodiazepine site are classified into three types; 
benzodiazepine agonists, benzodiazepine inverse agonists and benzodiazepine site 
antagonists. Benzodiazepine agonists are positive allosteric modulators, which 
include the classical benzodiazepines such as diazepam and flunitrazepam, and those
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agents which enhance GABA receptor responses. Recent studies have shown that 
binding of these agents results in an increase in the frequency of channel opening 
(Rogers et al., 1994) by increasing the affinity of the receptor for the agonist GABA 
(Lavoie & Twyman, 1996). Negative allosteric modulators have the opposite effect 
in reducing GABA receptor responses, and neutralising allosteric modulators block 
the action of the agonists and inverse agonists by competitively binding to the 
benzodiazepine site but have no effect on the chloride flux through the GABA 
receptor (Johnston, 1996; Sieghart, 1995). Also a range of agents which exhibit only 
intermediate effects compared to the agonist and inverse agonists are collectively 
called partial agonists and partial inverse agonists. The classification of a 
benzodiazepine site specific drug into one of these classes is then determined for 
GABA receptors of a particular subunit combination. The imidazopyridine zolpidem 
for example, acts as a full agonist at (X2p3Y2 and <^372 but is a partial agonist at 
0Csß3Y2 receptors. Rol5-4513 is a full inverse agonist on 0^372 receptors, a partial 
inverse agonist on 01^272 receptors and a partial agonist on 0^272 receptors 
(Whiting et a l, 1995).
4.3.5. General anaesthetics
A wide range of structurally unrelated anaesthetic agents have been demonstrated to 
exert their effects at least partially through the potentiation of GABA receptor 
responses (Pistis et al., 1997). These anaesthetics include the common inhalational 
anaesthetics halothane, enflurane, isoflurane, and diethyl ether, and the injectable 
anaesthetics ketamine, propofol, and alphaxolone. At low concentrations (similar to 
theraputic doses) these agents have been found to mostly potentiate GABA receptor 
mediated currents, whereas at higher concentrations these agents activate the 
chloride current directly (Sieghart, 1995). The effects of these agents does however 
show variance with different receptor subunit compositions (Lin et al., 1993; Sanna 
et al., 1995). GABA receptors comprising a l ,  a2 and a5, ßl and ß2 and 72 (S and 
L) subunits show positive modulation (Sanna et al., 1995), whereas receptors 
comprising a6 subunits are less sensitive (Krasowski et al., 1997), and those 
containing the £ subunit are insensitive (Davies et al., 1997). The direct activation of
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the GABA receptor by higher concentrations of anaesthetic appears to require a ß 
subunit indicating that this action may occur at an alternate binding site (Beleih et 
al., 1996; Sanna et al., 1995). GAB Ac receptors which are combinations of the pi 
subunits, are inhibited by the inhalational anaesthetics enflurane., halothane and 
isofiurane but unaffected by other anaesthetic agents (aiphaxolone, propofol) (Mihic 
& Harris, 1996) and glycine receptors have also been shown to be positively 
modulated by anaesthetics (Pistis et al., 1997). These results may indicate binding 
domains for these agents in conserved transmembrane regions of GABAa, GABAc 
and glycine receptors (Mihic et al., 1997) though the site for each agent may not be 
the same (Krasowski et al., 1998).
Propofol has been demonstrated to positively modulate recombinent GABA 
receptors containing combinations of a,ß and y subunits by varying degrees 
depending on the combination (Sanna et al., 1995). However, inclusion of the 
recently cloned e subunit into an a/ß combination confers propofol insensitivity to 
these receptors. Propofol has also been reported to be ineffective at homomeric p 1 
GABAc receptors (Mihic & Harris, 1996), though its effect on other forms of 
GABAc receptors has not been investigated.
Used at concentrations close to is therapeutic dose (9.2 - 56 pM in an anaesthetised 
patient’s serum), propofol has been demonstrated to enhance GABAa mediated 
inhibition in pyramidal hippocampal neurones from region CA1 (Albertson et al., 
1996). Furthermore, the effect of propofol on miniature spontaneous 1PSC recorded 
from cultured hippocampal neurones was to elongate the decay of these events while 
not affecting peak amplitude (Orser et al., 1994). In the same study, single channel 
recordings made from outside-out patches from the same cultured neurones indicate 
that at low concentration, propofol increases the frequency of GABA receptor 
channel opening in the presence of agonist.
4.3.6. Barbiturates
Like the general anaesthetics described above the barbiturates (pentobarbital, 
pentobarbitone, phenobarbital and secobarbital), have also been demonstrated to
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have both allosteric modulatory effects and direct activation effects (Sieghart, 1995). 
These effects are also somewhat subunit dependant with the a  subunit important for 
efficacy of the barbiturate induced potentiation and the direct activation at higher 
concentrations (Thompson et al., 1995). In contrast, homomeric p i GABAc 
receptors have been shown to be unaffected by pentobarbital (Mihic & Harris, 1996; 
Shimada et al., 1992), however the sensitivity to and effect of barbiturate on other 
GABAc receptor subunit compositions has not been reported.
4.4. GLYCINE
The amino acid glycine was also shown to exhibit inhibitory' actions on spinal 
neurones in the early 1960s (Curtis et al., 1961; Curtis et al., 1959). Subsequently, 
glycine has also been shown to meet all of the criteria of chemical transmitters and 
to act as an inhibitory transmitter (Van den Pol & Gores, 1988). Fast ionotropic 
glycinergic transmission has been demonstrated in the caudal regions of the CNS -  
the brainstem and spinal cord (Kotak et al., 1998; Lewis & Faber, 1996; Schneider 
& Fyffe, 1992), though the mRNA for the glycine receptor subunits (a l, a2, and ß) 
have been shown to be expressed throughout the brains (Sato et al., 1992). In the 
brainstem and spinal cord, the activation of glycine receptors was shown to activate 
a chloride conductance (Curtis et al., 1968) -  by opening an ion channel which is 
formed through the receptor complex (Betz, 1992). The responses of the neurones is 
an acute hyperpolarisation similar to that recorded in response to the activation of 
the ionotrophic GABA receptors and the mechanism of glycinergic inhibition is thus 
assumed to be the same as that of fast ionotropic GABAergic inhibition (Curtis et 
al., 1968).
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4.5. GLYCINE RECEPTORS
Belonging to the same superfamily of ligand gated ion channels as acetylcholine and 
GABA receptors, the glycine receptor is also thought to consist of a pentameric 
assembley of glycine receptor subunits (Betz, 1992; Langosch et al., 1990). To date, 
three a  subunits (al,a2 , and oc3) and Iß subunit have been cloned in rat, with the 
a2 subunit also having three splice variants (a2A,oc2B, and oc2*) and the a l  having 
a variant with an eight amino acid extension at its C-terminus ( a l ins) (Rajendra et 
al., 1997). Functional glycine receptors are composed of a combination of either a  
subunits alone, or in combination with ß subunits. The subunit combination which 
forms the expressed glycine receptor is developmentally regulated, such that the 
fetal glycine receptor is a pentomer of a2 subunits and the adult form is a 
combination of the a l  and ß subunits (Rajendra et al., 1997). Like the GABA 
receptor, the glycine receptor complex has an integral ion channel through the 
complex structure which is permeable to chloride ions and other monovalent anions 
(Rajendra et al., 1997).
Glycine receptors and mRNA for the subunits, have been localised throughout the 
CNS in rats (Betz, 1991; Sato et al., 1992; Van den Pol & Gores, 1988), however 
immunoreactivity to both the receptor and to glycine itself is diffuse outside the 
spinal cord and brainstem. Furthermore, synaptic activation of these receptors 
appears to be limited to synapses in brainstem and spinal cord, as GABA is thought 
to solely mediate fast inhibitory transmission in the rostral regions of the CNS (Flint 
et al., 1998). The role of the glycine receptors in the brain has not been established. 
Reports of non-synaptic activation of neocortical glycine receptors by the amino 
acid taurine during development (Flint et al., 1998) and effects of focally applied 
glycine on synaptic transmission in the cortex and hippocampus (Bemardi et al., 
1979; Ito & Cherubini, 1991), may suggest non-synaptic inhibitory or 
developmental functions.
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4.5.1. Glycine receptor antagonists
The convulsant alkaloid strychnine is a potent competitive inhibitor of the glycine 
receptor responses (Curtis et al., 1968) binding to a site on the a  subunits (Betz, 
1992). The IC50 for the strychnine block of the glycine receptor is 28 -  49 nM (Jonas 
et al., 1998; Shirasaki et al., 1991). Picrotoxin also inhibits the glycine receptor. 
Unlike the noncompetive block of the Ga BAa receptor, picrotoxin is a competitive 
antagonist at glycine receptors, with slightly higher affinity for a l  homomeric 
receptors over a l  ß heteromers (Rajendra et al., 1997).
4.6. RESULTS
4.6.1. Ce neurones express both GABA and glycine receptors
Individual Ce neurones responded to applications of both GABA and glycine (n = 
7/7) when applied separately by bath application, indicating expression of both 
Glycine and GABA receptors on these neurones. However, as a result of the 
relatively slow application method, these responses were quite variable from one 
application to the next. Respones to GABA and glycine were subsequently studied 
separately using iontophoretic application of the transmitter. This method enabled 
repeated application of transmitter at a constant concentration, and hence uniform 
responses could be evoked. Caesium based internal solutions were used to block 
potassium channels to isolate GABAa responses in the presence of putative GABAb 
receptors on these cells.
Glycine iontohporesis
Glycine was applied iontophoretically to eleven Ce neurones and responses recorded 
in increasing concentrations of strychnine. In control recordings (no strychnine) 
using high chloride internal solution, these responses reversed at 0 mV (Figure
4.1. A,B), and appeared as inward current deflections at membrane potential o f-60
A Steine B
1001
C  Control response 
glycine
+ bicuculline 
glycine
Figure 4.1. Application of glycine to Ce neurones by iontophoresis 
A. Responses to iontophoretically applied glycine (duration indicated by bar) 
at membrane potentials -80, -60, -40, -20, 0, +20 and +40 mV, recorded using 
cesium chloride internal solution. B. Current voltage relationship for 
iontophoretically induced glycine current for neurone shown in A. C. Glycine 
application at Vm -60 in control and in 10 pm bicuculline where spontaneous 
activity associated with the control response has been abolished.
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mV. Notably, these responses to applied glycine were often accompanied with an 
increase in the frequency of spontaneous synaptic activity (Figure 4.1.C). This 
activity was sensitive to the GABAa antagonist bicuculline (Figure 4.1.C), 
indicating that the increase in release frequency occurred at GABAergic terminals. 
The response current to iontophoretic glycine was not blocked by 10 pM bicuculline 
(Figure 4.1.C), but it as blocked in a dose dependent manner by strychnine (Figure 
4.2.A). Combining results from six neurones, a dose response curve for the 
strychnine block of the glycine current (Figure 4.2.B), revealed that the IC50 for this 
block was 0.079 pM, which is close to previously reported IC50 for the action of 
strychnine on glycine receptors on isolated cells and membrane patches (Jonas et al., 
1998; Shirasaki et al., 1991).
GABA iontophoresis
Iontophoresis of GABA also produced response currents which reversed at the 
chloride equilibrium potential (Figure 4.3.A,B). These currents were insensitive to 
the glycine receptor antagonist strychnine at 1 pM (1.44 ± 7.2% inhibition, n=3) 
(Figure 4.3.C). The GABA responses were sensitive to the GABAa antagonists 
bicuculline and SR95531 however. Recording responses in increasing 
concentrations of bicuculline (Figure 4.4.) revealed a biphasic block of the 
responses, with an initial effect between concentrations of 0.05 and 1 pM followed 
by a second rapid phase of inhibition between concentrations of 10 and 100 pM. 
This biphasic block was apparent on the inhibition curve constructed from data from 
six neurones, with the data being best fit by the sum of two sigmoid functions using 
the equation;
»/»Inhibition = a/(l+(IC50iow/c)2) + b/(l+(IC50h,gh/c)2)
where (a + b) was constrained to 100. The IC5010W and ICsohigh represent the IC50 for 
a low affinity binding site and high affininty binding site. ICsohigh of 0.12 pM was 
close to that reported by Jonas et al for bicuculline inhibition of GABAa receptors 
on patches pulled from spinal motorneurones (Jonas et al., 1998). The low affinity 
bicuculline binding site had an IC50 of 23.1 pM, which is twenty times higher than 
reported at spinal cord GABAa receptors (Jonas et al., 1998; Shirasaki et al., 1991).
Gly iontophoresis100-1
[ Strychnine ] (pM)
Figure 4.2. Inhibition of glycine currents by strychnine 
A. Reponses to iontophoretically applied glycine (duration indicated by 
bars) in increasing concentration of strychnine (0 - 1 pM). B. Inhibition 
curve for six neurones showing line of best fit of the function 
l/(l+l/(IC5o/c)), where the IC50 was 0.079 pM.
GABA Vm (mV)
C Control response 
GABA
+ strychnine 
GABA
Figure 4.3. Application of GABA to CeL neurones by iontophoresis.
A. Responses to iontophoretically applied GABA (duration indicated by bar) 
at membrane potentials -100, -80, -60, -40, -20, and +10 mV, using cesium 
gluconate based internal (Eci = -50 mV). B. Current-voltage relationship for 
the recordings shown in A. (filled circles) and for recordings from another 
neurone using cesium chloride based internal solution (open squares). Both 
relationships were fit with a linear function passing through the reversal 
potential for chloride for the internal used (Eci = -50 mV for cesium 
gluconate based internal and 0 mV for cesium chloride based internal).
C. Response to iontophoretically applied GABA, recorded in control at Vm - 
60 and with 1 pM strychnine in the extracellular solution.
A [bicuculline] (pM)
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Figure 4.4. Inhibition of GABA currents by bicuculline.
A. Average responses to iontophoretically applied GABA (duration 
indicated by bars, average of six applications) in increasing concentrations 
of bicuculline (0 - 100 pM). B. Inhibition curve for responses from six 
neurones (n = 3 - 6 for each point except 0.2 pM, where n = 2) showing
biphasic fit (equation a/(l/(l+(IC5o/c)2)+6/(l+(IC5o/c)), where a+b was 
constrained to equal 1) and IC50 values of 0.12 pM and 23.1 pM.
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As the action of bicuculline at the GABAa receptor is that of a competitive 
antagonist, it is possible that in the presence of higher concentrations of the agonist, 
the action of the antagonist may be affected by increased competition for the binding 
site. To address the possibility that the second phase of bicuculline inhibition was a 
secondary block at sites where the bicuculline had been ‘competed off by GABA 
application, we repeated the experiment using the higher affinity competitive 
antagonist SR95531. The iontophoretic responses recorded in increasing 
concentrations of SR95531 (Figure 4.5.A) showed a similar biphasic course of 
inhibition as the block by bicuculline. The combined results from four neurones 
(Figure 4.5.B) also provided an inhibition curve that was best fit using the sum of 
two sigmoid functions (see above). This fit again provided high affinity and low 
affinity IC50 of 0.01 and 0.62 pM respectively. The IC50 for SR95531 block of a 
GABA mediated IPSC has not been reported, however displacement studies using 
various GABA receptor ligands (muscimol, ['HJGABA) have reported the Kb for 
SR95531 as between 6.6 nM and 140 nM (Flamann et al., 1988; Ito et al., 1992; 
McCabe et al., 1988). Though the actual affinity of SR95531 for the GABA receptor 
is unclear, it has consistently been found to be 1 4 - 2 0  times more potent than 
bicuculline in these studies (Dunn et al., 1994; Ito et al., 1992; Yu & Ho, 1990). 
This difference in potency is also observed for the high affinity block of the 
iontophoretic responses by bicuculline and SR95531 in this study. This may indicate 
that the high affinity component of the bicuculline and SR95531 block seen here 
results from the binding of these antagonists to the same GABA receptor binding 
sites.
The presence of a low affinity antagonist site indicated the presence of a second 
GABA receptor type which was less sensitive to bicuculline and SR95531 block. 
The GAB Ac class of receptor have been shown to be at most only weakly inhibited 
by high doses of bicuculline (>100 pM), but partially sensitive to SR95531 
(Feigenspan & Bormann, 1994; Woodward et al., 1993) albeit at 20 times the dose 
required for GABAa inhibition ((Woodward et al., 1993). GABAc receptors are 
blocked by a selective competitive antagonist (1,2,5,6-tetrahydorpyridine-4- 
yl)methylphosphinic acid (TPMPA) (Chebib et al., 1998; Ragozzino et al., 1996) 
with an IC50 of approximately 0.7 pM (Kb = 2pM) for homomeric pi GABAc
A  [SR95531] (pM)
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Figure 4.5. Inhibition of GABA currents by SR95531.
A. Average responses to iontophoretically applied GABA (six 100 ms 
applications) in increasing concentration of SR95531 (0- 10 pM).
B. Inhibition curve for data from six neurones (n = 3 - 4 for each point 
except 0.0005, 0.001,and 30 pM where n = 1, 2 and 2 respectively)
showing biphasic fit (equation tf/(l/(l+(IC5o/c)2)+6/(l+(IC5o/c)), where 
a+b was constrained to equal 1) and IC50 values of 0.008 pM and 0.622 
pM.
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receptors (Ragozzino et al., 1996) but eight times less potent at homomeric p2 
GABAc receptors (Kb = 16 pM) (Chebih et al., 1998). To test the TPMPA 
sensitivity of the component of the GABA response blocked by the low affinity 
binding of bicuculline and SR95531, TPMPA was applied at 60 pM to iontophoretic 
responses in the presence of 10 pM bicuculline (Figure 4.6.). This dose of 
bicuculline has been used routinely to block GABAa mediated inhibition in previous 
studies (Collingridge et al., 1984; Singer & Berger, 1999; Williams & Johnston, 
1991) and would block the contribution of the high bicuculline affinity receptors by 
more than 99% (assuming an IC50 of 0.12 pM as described above). The 
iontophoretic currents in the presence of bicuculline were found to be reversibly 
blocked by 73% ± 1% by 60 pM TPMPA. These results indicate that the low 
bicuculline affinity site is also a binding site for the selective GABAc antagonist 
TPMPA and indicates the presence of a second GABA receptor with GABAc-like 
antagonist sensitivity on Ce neurones.
4.6.2. GABA receptors mediate the fast IPSC in Ce neurones
The presence of all three known chloride channel ionotropic receptors (GABAa, 
glycine and a putative GABAc receptor) on neurones of the Ce provided a number 
of possibilities for the composition of the synaptic inhibitory currents recorded in 
these neurones. Co-release of glycine and GABA has been demonstrated at synapses 
containing both glycine and GABAa receptors (Jonas et al., 1998,O'Brien, 1999 
#2127) which results in composite IPSC. In contrast, hippocampal pyramidal 
neurones which have been shown to express both glycine receptors (Sato et al., 
1992) and GABAa receptors, have IPSC which are mediated by GABA receptors 
only (Segal & Barker, 1984). Though the expression of GABAa and GABAc 
receptors on retinal neurones has been demonstrated both histologically (Enz et al., 
1996; Fletcher et al., 1998) and pharmacologically (Feigenspan et al., 1993; Qian & 
Dowling, 1993), only a few papers have demonstrated synaptic currents mediated by 
the GABAc receptors (Hartveit, 1999; Lukasiewicz & Shields, 1998). From these, 
no clear picture has emerged of the contribution of GABAc and GABAa currents to 
IPSC where both receptors may be activated.
Control BIC TPMPA
Figure 4.6. TPMPA blocks the iontophoretic GABA response insensitive 
to 10 pM bicuculline.
Iontophoretic responses to GABA, partially blocked by 10 pM 
bicuculline (BIC) were further blocked on application of 60 pm TPMPA 
(TPMPA). Responses shown are averages of six individual iontophoretic 
applications.
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To study the receptor types mediating the IPSC in the Ce we evoked electrically 
monosynaptic inputs from the 1CM region lying laterally to the CeL, and recorded 
from neurones within the CeL. The IPSC was isolated by blocking the glutamatergic 
EPSC, using either kynurenic acid (2 mM) or a combination of CNQX (10 pM) and 
D-APV (30 pM). To determine whether GABAa receptor mediated current was 
contributing to the evoked IPSC, we applied bicuculline (10 pM) to the extracellular 
solution. The control IPSC was blocked by on average 66.9 ± 3.3% (n = 19) by 
bicuculline at this concentration (Figure 4.7.A,C). Assuming that the synaptic 
GABA receptors are the same as those activated by the iontophoresis of GABA onto 
these cells, the effect of lOpM GABA would be to block the high bicuculline 
affinity GABAa receptors by more than 98.5%. This was also the case for the 
GABAa mediated IPSC recorded in hippocampal pyramidal neurones in region 
CA1, which were blocked by 98.3 ± 0.6% as a control experiment (Figure 4.7.B,C). 
Partial block of the IPSC by this concentration of bicuculline thus indicated a second 
contributing receptor to the IPSC.
Evoked IPSC responses were isolated in either kynurenic acid (2 mM) or CNQX 
and D-APV (10 and 30 pM respectively), and 10 pM bicuculline, to study the 
receptor underlying the non-GABAA component of the IPSC. The resultant IPSC 
recorded had a reversal potential similar to the control IPSC in both cesium chloride 
and caesium gluconate internals, at close to the reversal potential for chloride using 
these internals (0 and -52 mV respectively) (Figure 3.7.A,B). This indicated that the 
second IPSC component was a chloride current.
The selective glycine antagonist strychnine was applied to test whether the glycine 
receptors were mediating the second IPSC component. When applying glycine by 
iontophoresis, 1 pm strychnine had blocked the glycine receptor response by more 
than 98%. However, this concentration had no significant effect on the IPSC 
recorded in the presence of 10 pM bicuculline (0.35 ± 2.1%, n = 3) (Figure 4.8.). 
This indicated that the glycine receptors were not contributing to the IPSC. 
Furthermore, the addition of the GABA uptake inhibitor NO-711(1 pM) was able to 
prolong the decay of a train of IPSCs recorded in the presence of 10 pM bicuculline
A  control 10 pM BIC
2 x Stim
300 pA
200 ms
CeL CA1
Figure 4.7. The CeL IPSC is partially blocked by 10 pM bicuculline.
A. IPSC were evoked electrically, laterally to CeL in the presence of 
kynurenic acid (2 mM). Bicuculline (10 pM) applied in the extracellular 
solution partially blocked the IPSC, leaving a component which increases 
with increased stimulation strength. B. CA1 IPSC in control (light line) 
and blocked by 10 pM bicuculline (heavy line). C. The average effect of 
10 pM bicuculline on IPSC recorded in CeL compared to IPSC recorded 
in pyramidal neurones from the hippocampal CA1 region, (p < 0.05, n = 
19).
Control BIC strychnine
100 pA
200 ms
Figure 4.8. Strychnine has no effect on the bicuculline insensitive IPSCs. 
IPSCs were evoked electrically laterally to CeL (control) and bicuculline 
(10 pM) added to block the GABAa component (BIC). The remaining 
IPSCs were unaffected by strychnine (1 pM). (Average of six individual 
IPSCs shown).
Figure 4.9. The GABA uptake inhibitor NO-711 prolongs the IPSC decay. 
A IPSCs produced by a train of stimuli (5 stimuli at 50 Hz) in control 
(2mM kynurenic acid), in the presence of extracellular NO-711 and this 
response overlaid on IPSCs after washout of NO-711. (Averages of six 
individual IPSCs in each case.)
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(Figure 4.9.), indicating that these responses were activated by synaptic GABA 
release.
To confirm that the second GABA receptor type identified by the GABA 
iontophoresis was contributing to the IPSC, the effects of higher concentrations of 
bicuculline and the GABAc antagonist TPMPA were examined on the component of 
the IPSC remaining in 10 pm bicuculline. The component of the IPSC left in 10 pM 
bicuculline was significantly blocked by 60 pM TPMPA (66.2 ± 5.8%, n = 6, p < 
0.01) (Figure 4.10.A,D). As a control experiment, the same dose applied to 
hippocampal pyramidal cell IPSC (mediated by GABAa receptors only) had no 
significant effect (3.3 ± 4.3% block, n = 7) (Figure 4.10.C,D). Finally, applying 
TPMPA to the control CeL IPSC partially blocked the responses (36.8 ± 1.8%, n = 
6, p < 0.05), leaving a proportion of the IPSC similar to that blocked by bicuculline, 
which could be subsequently blocked by bicuculline (Figure 4.10.B,D).
The block by bicuculline of the iontophoretic GABA response had indicated two 
IC50 for this antagonist, with the effect of higher concentrations (50 -  100 pM) being 
close to complete block. As seen for these iontophoretic GABA responses, the effect 
of a higher concentration of bicuculline on the IPSC was also a greater block (86.7 ± 
2.9%, n = 4) (Figure 4.11.), but again not complete.
The component of the IPSC not blocked by 10 pm bicuculline mirrored the 
pharmacological profile of the low bicuculline affinity receptors identified by 
iontophoresis. Furthermore, the transmitter producing these bicuculline resistant 
IPSC was identified as GABA by blocking GABA uptake. These results taken 
together, indicated that the low bicuculline affinity GABA receptors were also 
contributing to the evoked IPSC.
TPMPA + wash
50 ms
CA1 (control,+TPMP A)
200 pA
100 ms
CeL CeL CA1 
(control) (in BIC)
Figure 4.10. TPMPA blocks the IPSCs left in bicuculline.
A. TPMPA (60 pM) was applied to laterally stimulated IPSCs in 10 pM 
bicuculline (BIC). The bicuculline resistant IPSCs were reversibly 
blocked (TPMPA + wash). B. A proportion of the control IPSCs similarly 
stimulated (Control) were also sensitive to TPMPA (60 pM) leaving 
IPSCs (TPMPA) which were blocked by bicuculline (BIC). C. CA1 
IPSCs recorded in control (light line) and TPMPA (heavy line). D. The 
average effect of TPMPA on control IPSCs, and IPSCs resistant to 10 pM 
bicuculline in CeL neurones, and the effect of the same dose o f TPMPA 
on IPSCs recorded in hippocampal pyramidal neurones from area CA1.
(* p < 0.05, ** p < 0.01, n = 6 for both experiments). (Average IPSCs 
shown)
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4.6.3. The low bicuculline affinity GABA receptors are less sensitive to 
picrotoxin than GABAa receptors
Both GABAa and GABAc receptors have been found to be blocked by picrotoxin, 
however the GABAc receptors have been shown to be less sensitive (Feigenspan et 
al., 1993; Qian & Dowling, 1994). Picrotoxin applied at 25 pM was found to 
completely block the GABAa mediated IPSC recorded in hippocampal pyramidal 
neurones in region CA1 (99.1 ± 0.3%, n = 4) (Figure 4.12.A,C). In contrast, the 
same dose only blocked the control CeL IPSC by 63.6 ± 9.1% (n = 3) (Figure 
4.12.B.C), and a much higher concentration (100 pM) was required for near 
complete block 96.7 ± 0.3 (Figure 4.12.B).
4.6.4. The actions of 1,4-benzodiazepines on the CeL GABA receptors
The homomeric p 1 GABAc receptor (and presumably the heteromers containing the 
p2 and p3 subunits) are not modulated by benzodiazepines as the binding of these 
drugs occurs at a site within the GABAa a  and y subunits. Sensitivity of the 
bicuculline resistant GABA receptor to the 1,4-benzodiazepine was investigated to 
establish if these receptors also lacked this site. Applied to the control CeL 
iontophoretic GABA response (no bicuculline), diazepam produced an insignificant 
increase in the response amplitude of 21.1 ± 18.8% (n = 5, Figure 4.13.A,D), 
Uniform control iontophoretic GABA responses were recorded in the presence of 
bicuculline (10 pM) and Diazepam (10 pM). In contrast to the control CeL 
responses, responses to applied GABA in the presence of bicuculline were reduced 
in amplitude by diazepam (Figure 4.13.B) by an average of 27.3 ± 8.1% (p < 0.05, n 
= 5, Figure 4.13.D). A control experiment using the same concentration of diazepam 
on GABA responses mediated solely by GABAa receptors on pyramidal 
hippocampal neurones in region CA1 (Figure 4.13.C) resulted in an increase in the 
response amplitude by an average of 51.7 ± 19.1% (p < 0.05, n = 5, Figure 4.13.D). 
The small effect of diazepam on the control CeL GABA response represents the net 
effect of diazepam modulation of both GABA receptor types, ie. the sum of the 
negative modulation of the bicuculline resistant type and the positive modulation of
control 10 pM BIC 100 pM BIC
Figure 4.11. Higher Doses of bicuculline block the CeL IPSCs.
IPSCs were evoked electrically laterally to CeL (Control*) and partially 
blocked by 10 pM bicuculline (lOpM BIC*). The remaining IPSCs were 
further blocked by a higher concentration of bicuculline (100 pM BIC*). 
(♦Averages of six individual IPSCs.)
A Control 25 pM PTX
B CAl (control, +PTX)
200 pA
100 ms
100 pm PTX
200 pA
50 ms
25pM lOOpM 25pM 
[Picrotoxin]
Figure 4.12. CeL IPSCs are less sensitive to picrotoxin than CAl IPSCs.
A. CeL IPSCs evoked by lateral stimulation (Control*) are partially 
blocked by 25 pM picrotoxin (25 pM PTX*), but further reduced by 
higher concentrations (100 pM PTX*). B. CAl IPSC recorded in control 
(light line*) and blocked by 25 pM PTX (heavy line*). C. Average block 
by 25 and 100 pM picrotoxin of laterally stimulated CeL IPSC, compared 
with complete block of IPSC recorded in CAl. (*Averages of six or 
more individual IPSCs)
Control
A CeL
B CeL
Control
C CAl
Control
Diazepam
__ 1 50 pA
1 s
Diazepam
Diazepam
1 s
B  120 -
100 - —
Ce (BIC) CAl Ce (control)
Figure 4.13. Effect of diazepam on GABA iontophoresis responses.
A. Diazepam (10 pM) effect on the control GABA response current of a 
CeL neurone (average of six responses). GABA iontophoresis duration is 
indicated by bars. B. Diazepam (10 pM) applied to the GABA iontophoresis 
response remaining after block of the GABAa component by 10 pM 
bicuculline (average of six responses shown). C. Diazepam effect on the 
GABAa mediated response of a hippocampal CAl neurone (average of six
responses shown). D. Average effect of diazepam on response amplitude for 
Ce neurone responses recorded in bicuculline (10 pM), CAl neurone 
responses and Ce neurone responses in control conditions (n = 5 for each 
experiment, p < 0.05).
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the GABAa type receptors. This indicates that like the GABAa receptors of the CA1 
neurones, GABAa receptors of the CeL are positively modulated by diazepam.
To confirm that the inhibitory effect of diazepam was also seen at synaptic 
responses mediated by the bicuculline insensitive GABA receptor, an IPSC was 
evoked by lateral stimulation in the presence of bicuculline (10 pM). Diazepam (1 
and 10 pM) was applied (Figure 4.14.A) and, as seen for the iontophoretic responses 
previously, the bicuculline insensitive IPSC were reduced by diazepam. The average 
block of the bicuculline resistant IPSC amplitude was 28.2 ± 7.0% by 1 pM 
diazepam (n = 5) and 42.2 ± 5.0% by 10 pM (p < 0.05, n = 5) (Figure 4.14.C). The 
1/2 peak width of the bicuculline resistant IPSC remained unaffected after diazepam 
block (10.3 ± 8.7% decrease in 1 pM, 4.4 ± 4.3% increase in 10 pM, n = 5 for each 
concentration (Figure 4.14.C)). In contrast to these results, control GABAa mediated 
IPSC recorded from pyramidal neurones from CA1 were not reduced in amplitude 
(34.0 ± 15.7% increase in 1 pM diazepam (n = 5), 34.0 ± 14.8% increase in 10 pM 
diazepam (n = 5)) but were increased in 1/2 peak width in 1 pM and 10 pM 
diazepam (16.6 ± 12.0% at 1 pM (n = 5), and 32.2 ± 11.9% (p < 0.05, n = 5), Figure 
4.14.B,C).
A more potent 1,4-benzodiazepine, flurazepam, also reduced the amplitude of the 
CeL IPSC recorded in bicuculline (Figure 4.15.A), with the average block by 
flurazepam (1 pm) of 36.6 ± 5.0% (p < 0.05, n = 9, Figure 4.15.C). Again only a 
small insignificant decrease in the 1/2 peak width (-6.5 ± 5.8%) accompanied this 
effect (Figure 4.15.C). The effect of flurazepam on the GABAa component of the 
CeL IPSC was consistent with the effect of these agents on GABAa receptors (as 
shown by the diazepam effect in CA1 IPSC previously). The GABAa mediated 
IPSC recorded in TPMPA (60 pM) being unaffected in amplitude (4.7 ± 5.5%, n = 
5) but significantly lengthened in 1/2 peak width (21.2 ± 3.0%, p < 0.01, n = 5) 
(Figure 4.15.B,C).
Although the reversal of the effect of a benzodiazepine negative allosteric modulator 
to a positive modulator has been shown for certain combinations of GABAa 
receptor subunits (Puia et al., 1991), the reversal of the classical positive
CeL Control BIC & Diazepam
200 pA
100 ms
CA1 Control Control & Diazepam
100 pA
100ms
C  , n CeL in BICoU I----------------------
40-
CA1
□  Amplitude 
|1 /2  width
-60
1 pM 
diazepam
10 pM 1 pM 10 pM
diazepam diazepam diazepam
Figure 4.14. Diazepam blocks IPSCs mediated by bicuculline insensitive 
GABA receptors.
A. Laterally evoked CeL IPSCs recorded in control (10 pM CNQX, 30 pM 
d-APV), bicuculline (10 pM) and diazepam (10 pM) with average IPSC in 
bicuculline overlaid. B. CA1 IPSC recorded in control (2 mM kynurenic 
acid), and diazepam (10 pM) with control IPSC overlaid. C. Effects of 1 
and 10 pM diazepam on amplitude and 1/2 width of bicuculline resistant 
IPSCs recorded in CeL compared to GABAa mediated IPSC recorded in 
CAL (p < 0.05, n = 5 for each experiment) (Average IPSCs shown).
TPMPA Flurazepam
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Figure 4.15. Flurazepam reduces the amplitude of the bicuculline resistant 
IPSCs and increases the decay of the bicuculline sensitive IPSCs.
A. IPSCs recorded in control (10 pM CNQX, 30 pM d-APV), bicuculline 
(10 pM) and flurazepam (1 pM) (with BIC overlaid - indicated by *).
B. IPSCs recorded in control (2 mM kynurenic acid), TPMPA (60 pM) 
and flurazepam (1 pM) (with TPMPA overlaid - indicated by *).
C. Average effect of flurazepam on IPSC amplitude and 1/2 peak width for 
IPSCs recorded in CeL in bicuculline (10 pM) (p < 0.05, n = 9) and 
TPMPA (60 pM) (p < 0.01, n = 5). (Average IPSCs shown.)
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modulators, such as diazepam and flurazepam, has not. To establish whether this 
effect was occuring at a specific benzodiazepine binding site, the benzodiazepine site 
antagonist Ro 15-1788 was used. This compound is a high affinity ligand for the 
benzodiazepine site, while not functional as an allosteric modulator of the receptor. 
It has been shown to be able to act as a competitive inhibitor for the benzodiazepine 
site, and antagonise the binding of other benzodiazepines (Sieghart, 1995). 
Application of Ro 15-1788 (1 pM) had no effect on the bicuculline resistant IPSC 
alone (1.3 ± 2.9% change in amplitude, n = 3), but pre-applying Ro 15-1788 blocked 
the negative modulation effect of flurazepam on the bicuculline insensitive 
component of the CeL IPSC (Figure 4.16.A) from the 36.6 ± 5.0% decrease seen 
previously, to an insignificant 1.9 ± 5.4% increase (n = 4) (Figure 4.16.B). The effect 
of diazepam was similarly reduced from 42.2 ± 5.0% in bicuculline only, to 2.1 ± 
1.5% (n = 3) in bicuculline and Ro 15-1788 (Figure 4.16.B). On washout of the Ro 
15-1788 (Figure 4.16. A), the effect of flurazepam was to again reduce the amplitude 
of the bicuculline resistant IPSC (n = 1).
4.6.5. The effect of propofol on the bicuculline resistant IPSC
Although GABAc receptors are modulated by some anesthetics, these effects are 
distinct from the modulation of GABAa receptors in that those agents negatively 
modulate the GABAc response. Other agents (propofol included) were found to have 
no effect at GABAc receptors but positively modulate GABAa responses. The effect 
of propofol on the bicuculline insensitive IPSC thus may also be a distinguishing 
pharmacological property. Applying propofol (10 pM) to the laterally stimulated 
bicuculline resistant IPSC (Figure 4.17.A) resulted in no significant change to either 
IPSC amplitude or 1/2 peak width (0.53 ± 8.1% increase in amplitude, and 6.9 ± 
12.9% decrease in 1/2 width, n = 3, Figure 4.17.C). The 1/2 width of GABAa 
mediated IPSC recorded in hippocampal pyramidal neurones of the CA1 region 
(Figure 4.17.B) were increased by the same concentration of propofol by 136.9 ± 
21.8% (p < 0.05, n = 3), while the amplitude of these responses was unchanged (0.3 
± 13.9% of control, n = 3) (Figure 4.17.C).
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Figure 4.16. Ro 15-1788 inhibits the flurazepam block of bicuculline 
insensitive IPSCs.
A. Plot of normalised IPSCs recorded in kynurenic acid and bicuculline (2 
mM and 10 pM respectively) in control (1), Ro 15-1788 (1 pM) (2), Ro 
15-1788 and flurazepam (1 pM) (3), after washout to control (4) and in 
flurazepam (1 pM) (5). B. Average effect of flurazepam on laterally 
evoked CeL IPSCs in bicuculline (p < 0.05, n = 9) and in bicuculline and 
Ro 15-1788 (n = 4). (IPSCs shown are averages of six individual IPSCs.)
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Figure 4.17. CeL IPSCs mediated by bicuculline resistant GABA receptors 
are insensitive to propofol.
A. Laterally stimulated CeL IPSCs in bicuculline (10 pM), bicuculline and 
propofol (10 pM) and these responses overlaid. B. GABAa mediated 
IPSCs recorded in a pyramidal hippocampal neurone in control, propofol 
(10 pM), and these responses overlaid. C. Average effect of propofol on 
CAl IPSCs compared to CeL IPSCs recorded in bicuculline (p < 0.05, n = 
3 for each location). (IPSCs shown are averages of six individual IPSCs.)
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4.6.6. The effect of pentobarbitone on the bicuculline resistant IPSC
Like the benzodiazepines, barbiturates have also been found to be specific 
modulators of GABAa receptors. The effect of the barbiturate pentobarbitone was 
also examined on the bicuculline resistant GABA response.
The bicuculline resistant component of the CeL IPSC was positively modulated by 
the addition of a low concentration of pentobarbitone (25 pM) to the extracellular 
solution (Figure 4.18.A), however the extent of this modulation was less than that 
shown by the control GABAa mediated IPSC recorded in CA1 (Figure 4.18.B). 
Whereas the CA1 IPSC was increased in 1/2 width by 166 ± 29.5% (p < 0.01, n = 4), 
the bicuculline resistant component of the CeL IPSC was increased by only 32.7 ± 
11.8% (p < 0.05, n = 3). Furthermore, the amplitude of the control CA1 response 
was not changed by pentobarbitone (2.6 ± 24.2% increase, n = 4), but the CeL IPSC 
was reduced in amplitude by 21.5 ± 5.7% (p < 0.05, n = 3).
Addition of higher concentrations of pentobarbitone (100 pM), sufficient to directly 
activate GABA receptors, did so on both CeL neurones in the presence of 
bicuculline and CA1 neurones. This phenomenon is believed to occur at a site 
distinct from the site of action for the modulation effect, and can occur even in the 
absence of the agonist GABA (Sieghart, 1995). As both GABAa and GAB Ac-like 
receptors are directly activated by 100 pM pentobarbitone (even in the presence of 
bicuculline) the direct activation current in CeL neurones could have resulted from 
activation of either or both receptor types.
4.6.7. GABAb responses were not seen in CeL neurones
Bath application of the selective GABAb antagonist baclofen produced no change in 
membrane resistance, nor did it activate any significant potassium currents (n=3). 
Isolated IPSC recorded using potassium methylsulfate based internal solution show 
no slow IPSC components similar to those previously recorded postsynaptically in 
hippocampus and nucleus reticularis thalami (Ling & Bernardo, 1994; Ulrich & 
Huguenard, 1996). These results suggest that GABAb receptors are not present at
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Figure 4.18. CeL IPSCs mediated by bicuculline resistant GABA receptors 
are show less modulation by pentobarbitone.
A. Laterally stimulated CeL IPSCs in bicuculline (10 pM), bicuculline and 
pentobarbitone (25 pM) and these responses overlaid. B. GABAa 
mediated IPSCs recorded in pyramidal hippocampal neurone in control, 
pentobarbitone (25 pM), and these responses overlaid. C. Average effect 
of pentobarbitone on CAl IPSCs compared to CeL IPSCs recorded in 
bicuculline (p < 0.01, n = 4 for CAl, p < 0.05, n = 3 for CeL). (IPSCs 
shown are averages of six individual IPSC.)
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high density on these neurones, however the recordings were made at room 
temperature which may affect the size of the GABAb response, rendering it 
undetectable.
4.7. DISCUSSION
4.7.1. Two types of GABA receptors are expressed by ceL neurones.
Although the neurones of the Ce express both glycine and GABA receptors, the fast 
inhibitory transmission at CeL synapses is mediated by GABA receptors only. Two 
ionotropic GABA receptors are found on Ce neurones, one is typical of the GABAa 
type receptor, having high affinity for the competitive antagonists bicuculline and 
SR95531. This receptor mediates approximately 60% of the IPSC resultant from the 
activation of lateral monosynaptic inhibitory inputs. The other GABA receptor 
contributing to the IPSC is less sensitive to the antagonists SR95531, bicuculline, 
and the antagonist picrotoxin than GABAa receptors expressed by hippocampal 
pyramidal neurones, and sensitive to the GABAc antagonist TPMPA. Furthermore, 
the bicuculline insensitive IPSC mediated by these receptors was blocked by the 1,4- 
benzodiazepines diazepam and flurazepam, unaffected by the anaesthetic propofol 
and less sensitive to the barbiturate pentobarbitone than hippocampal GABAa 
responses.
4.7.2. GABAa or GABAc?
The aim of the preceding experiments was to establish the nature of bicuculline 
resistant GABA receptors, in terms of the pharmacological profile of the receptor. 
The drugs used have typical effects on expressed GABAa and GABAc receptors. 
The pharmacological profile exhibited by the bicuculline resistant GABA
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receptors was not consistent with either of these receptors however, and arguments 
can be made for this receptor having properties normally associated with both.
The low bicuculline affinity receptors were less sensitive to picrotoxin and 
SR95531 than GABAa receptors and sensitive to the specific GABAc antagonist 
TPMPA. These results are consistent with GABAc type receptors (Qian et al., 
1998). The bicuculline resistant receptor was also insensitive to propofol, which is 
also consistent with the reported pharmacology of GABAc receptors (Mihic & 
Harris, 1996). However, the fact that this GAB Ac-like receptor is sensitive at all to 
bicuculline is at odds with all present data concerning the known homomeric p 
subunit combinations which have been shown to be insensitive to bicuculline in the 
100 pM range (Qian et al., 1998). The effects of the 1,4-benzodiazepines and the 
barbiturate pentobarbitone at these receptors is also inconsistant with the reported 
insensitivity of GABAc receptors to these drugs (Bormann & Feigenspan, 1995; 
Johnston, 1996; Shimada et al., 1992). Indeed the presence of a binding site for the 
benzodiazepines indicates the presence of GABAa ex and y subunits as part of the 
receptor structure, as these subunits have been shown to form the binding site for 
these drugs (Macdonald & Olsen, 1994; Sieghart, 1995; Sigel & Buhr, 1997).
If the low bicuculline affinity receptors are composed of GABAa receptor subunits 
including an a  and a y type, then this combination would be unique in its 
modification by classical 1,4-benzodiazepines such as diazepam and flurazepam. 
Though variability in the efficacy of diazepam (including insensitivity) has been 
shown for a range of alternate a  and y subunit compositions (Costa & Guidotti, 
1996; Puia et al., 1992; Puia et al., 1991) none of the a,ß and y combinations 
examined have shown negative allosteric modulation by diazepam. The only 
classical benzodiazepine known to act as a negative modulator is 4’- 
chlorodiazepam, though this action is thought to occur at a different site than the 
positive modulation as it is not antagonised by the specific site antagonist 
flumazenil (Ro 15-1788). The reversal of other positive modulators which act at the 
benzodiazepine site has been reported for the imidazopyridines alpidem and 
zolpidem, at recombinant GABA receptors containing a 3 , ßi and yi and ct2 ,ßi and yi
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subunits respectively (Puia et al., 1991). Furthermore, the reversal of the action of 
negative allosteric modulators which act at the benzodiazepine site (becoming 
positive modulators) has been demonstrated, with the ß-carboline derivatives 
DMCM and ß-CCM acting as positive modulators of recombinant GABA receptors 
containing ai, (X2, 0C3, and 0,5 with ß« and yi subunits, and di and otz with ß; and yi 
subunits respectively (Puia et al., 1991). These effects are all coincident with the 
presence of a yi subunit in the GABA receptor complex. It is feasible in light of 
these results and the fact that the expression of yi is high in the Ce (Wisden et al., 
1992) that the inhibitory effects of the classical benzodiazepines on the receptors in 
CeL are also the result of these agents binding to GABA receptor which is a 
combination of known GABAa subunits (including a yi subunit) which has not been 
examined for benzodiazepine effect. One such possibility is the e subunit.
Functional recombinant GABAa receptors containing the e subunit expressed in 
combination with oti and a  2 with ßi and ß3 subunits expressed in HEK-293 cells 
were found to be insensitive to propofol and less sensitive to pentobarbital than otzßi 
receptor complexes (Davies et al., 1997). Furthermore the sensitivity of these 
receptors to bicuculline and picrotoxin was also less that expected for typical 
GABAa responses (73.6 ± 9.3% block by 10 pM bicuculline and 82.5 ± 7.4% block 
by 10 pM picrotoxin), and these receptor showed slightly higher agonist sensitivity. 
The different bicuculline and agonist may also indicate some differences in the 
agonist binding site, which may provide the sensitivity to the constricted GABA 
analogue and GABAc receptor antagonist TPMPA. Finally, and perhaps 
coincidentally, the £ subunit is also highly expressed in the amygdala (Davies et al., 
1997).
While the subunit combinations expressed with the £ subunit in the recombinant 
study by Davies et al would not be expected to be modulated by benzodiazepines in 
the absence of a y subunit, it is conceivable that alternate combinations of subunits 
with £ (including the yi subunits both highly expressed in amygdala) may also 
provide unusual anaesthetic and benzodiazepine pharmacology. Alternately, it is not 
inconceivable that a previously undescribed variant of a known GABAa subunit, a 
novel subunit or one of the p type subunits may instead confer this unusual
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benzodiazepine pharmacology by being incorporated into a receptor with the a  and y 
subunits required for forming a benzodiazepine site as has been suggested for 
recently described bicuculline insensitive GABA responses in rat spinal dorsal horn 
which also show benzodiazepine sensitivity (Park et ai, 1999).
In conclusion, these results also demonstrate the presence of two pharmacologically 
distinct GABA receptor subtypes on CeL neurones. One type is typical of GABAa 
receptors elsewhere in the brain, being blocked by low concentrations of bicuculline 
and SR95531, and being positively modulated by the 1,4-benzodiazepines diazepam 
and flurazepam. The other type of receptor has pharmacological properties similar to 
both GABAa receptor types -  modulation by 1,4-benzodiazepines (albeit negative 
modulation) and pentobarbitone, and insensitivity to propofol (those containing the e 
subunit), and to GABAc receptor types -  insensitivity to propofol and sensitivity to 
block by TPMPA, and higher doses of picroloxin and SR95531.
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5. THE SYNAPTIC DISTRIBUTION OF TWO GABA 
RECEPTORS ON CeL NEURONES
5.1. INTRODUCTION
5.1.1. Co-localisation of GABA receptors
Differential synaptic distribution of distinct GABAa receptor subunits at different 
synapses on the same neurone has been demonstrated histologically (Fletcher et al., 
1998; Gustincich et al., 1999; Nusser et al., 1996) suggesting that compositionally 
distinct GABA receptors are localised at separate synapses. GABAc receptors have 
also been shown histologically to be localised to separate synapses to GABAa 
receptors (Fletcher et al., 1998; Koulen et al., 1998). In the previous chapter we 
described two pharmacologically distinct GABA receptors contributing to synaptic 
currents on CeL neurones. Both receptors were found to contribute to the large 
postsynaptic inhibitory currents in response to electrical stimulation of multiple 
presynaptic fibres. This chapter will address the synaptic co-localisation of these 
receptors at the individual synapses on CeL neurones by examining the 
pharmacological effects of bicuculline and TPMPA at individual synapses on CeL 
neurones.
5.1.2. Miniature spontaneous IPSC
In the presence of the sodium channel blocker tetrodotoxin, neurones are unable to 
fire action potentials (Takahashi, 1984). Under these conditions, small spontaneous 
synaptic responses can be recorded as vesicles of transmitter are spontaneously 
released from presynaptic terminals (Collingridge et al., 1984; Fatt & Katz, 1952; 
Takahashi, 1984). These spontaneous responses -  called miniature postsynaptic 
currents (mPSCs) or potentials (mPSPs), are believed to be responses from a single 
postsynaptic site to the release of a single vesicle of neurotransmitter (Edwards et 
al., 1990; Katz, 1978). As such, spontaneous PSCs and PSPs have been studied
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extensively for the information that they reveal about the unitary nature of synaptic 
transmission such as release probability, quantal size and the kinetics of the post 
synaptic response.
One of the most useful features about studying mPSC’s is that these responses 
result from the activation of single postsynaptic site. This has been exploited in 
pharmacological studies to determine the receptors underlying the postsynaptic 
response (Bekkers & Stevens, 1989; Legendre, 1997; McBain & Dingledine, 1992). 
Similarly, the effects of bicuculline and TPMPA were examined on the mIPSC 
population recorded in CeL neurones to determine the contribution of the GABAa 
and the bicuculline resistant GABA receptors to postsynaptic currents at individual 
synapses on these neurones.
5.2. RESULTS
5.2.1. The effects of BIC and TPMPA on CeL mIPSCs
To determine whether both the GABAa and the bicuculline resistant GABA 
receptors contribute to synaptic currents at individual synapses on CeL neurones, 
we examined the effects of the antagonists bicuculline and TPMPA on the 
miniature spontaneous IPSCs (mIPSCs) recorded in tetrodotoxin (TTX) and 
kynurenic acid to block spontaneous glutamatergic responses. Membrane current 
was filtered at 5 kHz and sampled at 10 kHz in consecutive 3 second sweeps. The 
sweeps were then digitally refiltered at 1 kHz, and individual events were detected 
using a variable amplitude template. The template function was a sum of a rising 
exponential function (with the rise time set to 1 ms) and a decay exponential (with 
the decay time constant set to 12 ms). Events were recorded with a 10 ms baseline 
and rejected if another event occurred within 60 ms of the onset of the rising phase. 
Experiments were performed at Vm -60 mV, using CsCl based internal solution.
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Two types of miniature PSCs were collected in control conditions at Vm -60 (Figure 
5.1.A,B,C), which could be disinguished by rise and decay kinetics. The first type 
was fast rising and fast decaying mPSC with similar rise time (less than 1 ms) and 
decay time (less than 3 ms) to previously reported AMPA mediated EPSC (Bekkers 
& Stevens, 1996; Jonas ei a/., 1993). These fast events were not present when 
recording in either CNQX or kynurenic acid (Figure 5.1.D), confirming that these 
events were mediated by glutamate receptors. The second type of events recorded in 
control conditions (5.1.C) were slower in rise time and decay and were not affected 
by kynurenic acid (5.1.D). Furthermore, the slow events were outward currents at 
depolarised membrane potentials (-30 mV, 0 mV - Figure 5.2.B,C respectively) and 
inward at hyperpolarised potemtials (-70 mV - Figure 5.2.A), indicating that they 
were chloride mediated mIPSCs. The fast decaying events were inward at negative 
membrane potentials, reversing at Vm 0 (Figure 5.2.C) and were thus mEPSCs.
The slow decaying mIPSCs, isolated in kynurenic acid or CNQX/APV (Figure 
5.3.A,B), had an average 10 -  90 % rise time of 1.5 ± 0.1 ms (n = 14 cells), and 
decay usually best fit by two exponentials with time constants of 14.5 ± 0.9 ms for 
the fast decay phase and 57.9 ± 7.2 ms for the slow. These rise and decay times are 
similar to previously reported GABAergic mIPSCs recorded under similar 
conditions using similar techniques (Ropert et al., 1990). Applying picrotoxin (100 
pM), or bicuculline (10 pM) and TPMPA (100 pM) to these events in kynurenic 
acid blocked all events (Figure 5.3.C), indicating that these events were mediated by 
GABA receptors as seen previously for the evoked IPSC.
To determine the contribution of GABAa receptors to the mIPSCs, bicuculline was 
applied at 3 pM. This concentration was at the top of the first phase of the 
bicuculline dose response curve (Figure 4.4.), and according to the calculated IC50 
would block more that 94 % of the GABAa receptor mediated current but only 10 % 
of the bicuculline insensitive current. This would minimise the low affinity block of 
the bicuculline resistant component to maximise the amplitude of the bicuculline 
insensitive GABA events, and thus facilitate their detection. Furthermore, this dose
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Figure 5.1. CeL mEPSCs are fast rising and decaying.
A. Membrane current recordings showing spontaneous mPSCs in control 
recording conditions. Individual slow ( •  in A) and fast ( O in A.) decaying 
mPSCs (B. and C. respectively), and the average of these events (heavy line 
under) fit with a single exponential (light line overlaid). The decay constant 
was 12.9 ms for the slow decaying mPSC average and 3.4 ms for the fast 
decaying average. D. Membrane current recordings in 2 mM kynurenic acid 
with only slow decaying events evident.
Figure 5.2. Slow mPSCs reverse with membrane depolarisation.
Membrane current recordings in TTX, at membrane potentials -70 mV (A), 
-30 mV (B) and 0 mV (C). Note the presence of inward fast decaying 
events (O) in A and B but not C, and the inward slow decaying events ( •  ) 
in A, which are outward in B and C.
A  + kynurenic acid
O O
20 ms
C +TPMPA, BIC
Figure 5.3. CeL mIPSCs are blocked by bicuculline and TPMPA.
A. Membrane current recorded in TTX (0.5 pM) and kynurenic acid (2 
mM) showing spontaneous mIPSCs. CsCl based internal solution was 
used and recordings were made at vm -60. B. Individual events captured 
from A. (indicated by O) and the average of all events captured from A. 
(heavy line at right) fit with a single exponential with time constant 17.8 
ms (light line overlaid). C. Membrane current recordings made in TTX, 
kynurenic acid, bicuculline (10 pM) and TPMPA (100 pM).
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is greater than that used previously to block GABAa mediated mIPSCs in 
hippocampus (Edwards et al., 1990).
Spontaneous mIPSCs were recorded in the presence of kynurenic acid and 
bicuculline and TPMPA were applied (Figure 5.4.A,C). After application of either 
drug, mIPSCs of similar rise time and decay time were recorded, however the 
amplitude of individual events was smaller than those seen in control (5.4.B,D). 
Bicuculline reduced the average mIPSC amplitude (Figure 5.5.A), by an average of 
71.1 ± 6.2 % (p < 0.01, n = 6), with the cumulative frequency histogram of peak 
amplitude was shifted to the left for the entire amplitude range (Figure 5.5.B). 
Bicuculline however did reduce the mIPSC frequency (Figure 5.5.C, 12.2 ± 3.58 %, 
p < 0.05, n = 3). Applying the antagonist TPMPA produced a partial block of the 
average mIPSC of 37.5 ±4.1 % (p < 0.01, n = 9) (Figure 5.6.A). TPMPA was also 
found to shift the cumulative frequency histogram for mIPSC peak amplitude to the 
left (Figure 5.6.B), however the TPMPA plot was found to converge with the 
control plot at high amplitudes. This result may be indicative of insensitivity of 
some large mIPSC events to TPMPA. TPMPA had no significant effect on the 
mIPSC frequency (Figure 5.6.C), indicating that in control recording conditions 
there are no synapses whose responses are mediated solely by the bicuculline 
resistant GABA receptors.
The slight reduction of mIPSC frequency after bicuculline block has two potential 
causes. The first is that the reduction of smaller amplitude control mIPSCs by the 
average block of bicuculline (63.2 %) would render these events too small to be 
detected from the background noise level of around 2 pA peak to peak. The second 
possibility was that there were a small number of control events that were 
completely blocked by bicuculline, thus reducing the frequency of events. This 
possibility may also be consistent with the suggestion that some larger events being 
insensitive to TPMPA. It is probable that both of these factors contributed to the 
reduction in mIPSC frequency, and that an even smaller number of events than those 
indicated by the decrease in mIPSC frequency are mediated by GABAa receptors 
only. To establish the nature of this putative GABAa mIPSC population, by 
examining the effect of bicuculline, a larger sample of mIPSCs in control and in
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Figure 5.4. M iniature spontaneous IPSCs recorded in bicuculline and 
TPMPA.
Control mIPSCs were recorded in the presence o f 0.5 pM tetrodotoxin, 
before application o f either A. bicuculline (3 pM), or C. TPMPA (60 pM). 
B. and D. Average mIPSCs from recordings in A. and C. respectively
Control BIC
S> 0.5-
Current (pA)
C 1.2i
Control BIC
Figure 5.5. Miniature IPSCs are partially blocked by bicuculline.
A. Average mIPSC amplitude for events collected in control and in 3pM 
bicuculline (n = 3, p < 0.05). B. Cumulative frequency histogram for 
mIPSCs collected in three experiments showing a shift to the left when in 
bicuculline (diamonds). C. Frequency of mIPSCs in control and in 
bicuculline (n = 3, p < 0.05).
Control TPMPA
Current (pA)
C 1.2 ,
Control TPMPA
Figure 5.6. Miniature IPSCs are partially blocked by TPMPA.
A. Average mIPSC amplitude for events collected in control and in 60 pM 
TPMPA (n = 6, p < 0.05). B. Cumulative frequency histogram for mIPSCs 
collected in six experiments showing a shift to the left when in TPMPA 
(squares). C. Frequency of mIPSCs in control and in 60 pM TPMPA (n = 
6) .
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bicuculline was required, which would reveal a large enough sample of these events 
for satisfactory analysis.
5.2.2. Increasing asynchronous release with hypertonic sucrose
To increase the total number of events to allow us to detect a putative GABAa 
mediated subpopulation, we applied hypertonic sucrose solution locally to the 
surface of the slice around the neurone from which we were recording. This method 
increases the rate of asynchronous release of glutamatergic mEPSC (Bekkers & 
Stevens, 1989) without affecting the post synaptic response amplitude or kinetic 
properties (Bekkers & Stevens, 1989; McBain & Dingledine, 1992).
Applying hypertonic sucrose to the surface of the slice consistently produced an 
increase in mIPSC frequency. However, in 9 out of 12 neurones where the sucrose 
induced an increase in mIPSC frequency, a population of events which rarely 
observed in control conditions became prominent (Figure 5.7.A,B). These events 
were typically greater than 100 pA in amplitude and had faster rise times than the 
control population. In control recordings where they were detected, the frequency of 
these events was 0.02 ± 0.002 Hz (n = 6). In the same cells during sucrose 
applications the frequency of similar amplitude and rise time events was 0.31 ± 0.01 
Hz (n = 6, p < 0.01). The average amplitude of mIPSCs collected when these large 
events were induced by sucrose application, was 35.4 ± 3.3 pA, compared with 20.4 
± 2.1 pA for control mIPSCs, a 73.5 % increase (Figure 5.7.C, p < 0.01, n = 9). The 
10 -  90 % rise time of 1.1 ±0.1 ms was also faster than the control average mIPSC 
1 0 - 9 0  % rise time of 1.5 ± 0.1 ms (a 22.4 % decrease p < 0.01, n = 9, Figure 
5.7.D).
5.2.3. Large fast rising events induced by sucrose are insensitive to TPMPA 
but blocked by bicuculline
To determine whether the large sucrose induced events were also mediated by both
Sucrose
Figure 5.7. Hypertonic sucrose application reveals larger mIPSCs.
A. Hypertonic sucrose solution (500 mM) applied to the surface of the 
slice induced higher mIPSC frequency and revealed large events seen at 
very low frequency in control. B. Scatter plot of rise time vs. amplitude 
showing large amplitude events with fast rise times in sucrose (open 
circles) where none can be seen in control (closed circles). Average 
amplitude (C.) and rise time (D.) of mIPSCs in control and sucrose (p < 
0.01, n = 9).
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types of GABA receptors, we applied sucrose in the presence of bicuculline and 
TPMPA. After a control sucrose response of large fast rising mIPSCs was obtained, 
sucrose was applied in the presence of bicuculline (Figure 5.8.A). Average mIPSC 
recorded in bicuculline were not significantly different in amplitude (9.0 ± 1.6 pA in 
control compared to 8.9 ± 2.2 pA in sucrose, 6.0 ± 10.7 % increase, n = 3) or rise 
time (1.9 ± 0.5 ms in control compared to 2.1 ± 0.5 ms in sucrose, 11.3 ± 5.3 % 
increase, n = 3) (Figure 5.8.C,D) yet an increase in the frequency of the small 
amplitude events was seen.
Applying sucrose in the presence of TPMPA (Figure 5.8.B) in contrast, produced 
both a significant increase in average amplitude, (15.2 ± 2.9 pA in control compared 
to 29.7 ± 1.7 pA in sucrose, 103.7 ± 25.4 % increase, p < 0.01, n = 3) and significant 
decrease in 10 - 90% rise time (1.9 ± 0.3 ms in control compared to 1.5 ± 0.3 ms in 
sucrose, 17.1 ± 5.1 % decrease, p < 0.05, n = 3) (Figure 5.8.C,D). The average 
mIPSC recorded in TPMPA, in control and in sucrose, are smaller than of those 
recorded without TPMPA. This is due to a high proportion of smaller events, in 
control and sucrose being further reduced by TPMPA. However, the largest 10 % of 
mIPSCs collected during sucrose application in control and in TPMPA are not 
significantly different in peak amplitude (control 118.4 ± 7.4 pA vs. TPMPA 113.4 
±2.1 pA, n = 3) or 10-90 % rise time (control 1.0 ± 0.5 ms vs. TPMPA 1.1 ±0.3 ms, 
n = 3) as shown for the averages shown in Figure 5.9. - indicating that this reduction 
is due to blockade of small events by TPMPA. This also demonstrates that the large 
events induced by sucrose are not sensitive to TPMPA blockade.
These results indicate that the large, fast rising events induced by sucrose which are 
not affected by TPMPA and absent in bicuculline are events mediated by bicuculline 
sensitive GABAa receptors only. Events of similar amplitude and rise time occur at 
extremely low frequency or not at all in control recordings without hypertonic 
sucrose. In cells where they were seen, the average frequency of these events was 
0.02 ± 0.002 Hz (n = 6), whereas control mIPSC frequency was 1.62 ± 0.3 Hz (n = 
7). Thus two populations of mIPSCs are recorded in CeL neurones, One is a small 
population of large amplitude fast rising GABAa mediated events which occur at 
very low frequency in control, but may be seen at higher frequency when release is
A Control SUCROSE +BIC SUCROSE
|  Control 
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Control BIC TPMPA Control BIC TPMPA
Figure 5.8. Bicuculline blocks large sucrose induced mIPSCs.
A. Application of hypertonic sucrose in control and in bicuculline (10 
pM). B. Application of sucrose in control and in 100 pM TPMPA.
C. Average mIPSC amplitude in control, BIC and TPMPA in control and 
in sucrose (p < 0.05, n = 3). D. Average mIPSC rise time in control, BIC 
and TPMPA, in control and in sucrose (p < 0.05, n = 3).
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Figure 5.9. Large sucrose induced mIPSCs are TPMPA insensitive.
A. Average of largest 10% of mIPSCs collected during sucrose appliation in 
control (thin line) and in 100 pM TPMPA (thick line), from experiment 
shown in Figure 6.5. Average mIPSC amplitude (B.) and rise time (A.) for 
largest 10% of responses induced by hypertonic sucrose in control and 
TPMPA, (n = 3 cells).
64
increased using hypertonic sucrose. The second constitutes the vast majority of 
events occurring in control recording conditions, and are slower rising smaller 
amplitude mIPSCs which are mediated by both GABA receptors.
5.2.4. Pure GABAa synapses are located on the somata of CeL neurones
The fact that the pure GABAa mediated mIPSCs recorded in hypertonic sucrose are 
significantly faster rising than the control population of mIPSCs, may be indicative 
of the localisation of these synapses closer to the soma of the neurone, as has been 
demonstrated for mEPSCs (Bekkers & Stevens, 1996; Williams & Johnston, 1991). 
To establish the nature of mIPSCs at somatic and dendritic synapses, hypertonic 
sucrose solution was applied focally under IR visualisation of the cells to the soma 
or to dendrites 50 -  100 pM from the soma. In three cases, lucifer yellow was 
included in the recording pipette and in the sucrose solution and fluorescence was 
recorded to visualise the neurones and their dendrites, and to indicate the extent of 
sucrose spread.
Focal application of sucrose to the soma of CeL neurones (Figure 5.10.B) induced a 
high frequency burst of spontaneous mIPSCs (Figure 5.10.A), which were 
predominantly large in amplitude and fast rising (n = 3) (Figure 5.10.C). The average 
mIPSC collected during sucrose application was 327.9 % larger than in control (80.9 
pA compared to 19.3 pA in control) and 36.4 % faster in 10 -  90 % rise time (0.7 ms 
compared to 1.1 ms in control). Histogram plots of events collected in control and 
sucrose show predominantly small amplitude events in control conditions, but larger 
events during sucrose application (Figure 5.10.E). Similarly, the distribution of rise 
times in control is spread in control, but less so in sucrose (Figure 5.10.F).
In contrast, focal application of sucrose to dendrites (Figure 5.1 l.B) increased the 
frequency of events of similar size as recorded in control conditions (n = 4) (Figure 
5.8.A,C). The average mIPSC collected in control and in sucrose are of similar 
amplitude (19.5 pA in control and 20.2 pA in sucrose), however 10 - 90 % rise time 
was slightly reduced in sucrose (1.0 ms in control and 0.9 ms in sucrose) (Figure 
5.1 l.D). Histogram plots of mIPSC amplitudes reflect these results with similar 
histogram distributions for peak amplitude in control and sucrose (Figure 5.1 l.E),
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Figure 5.10. Focal somatic application of hypertonic sucrose.
A. Sucrose was applied under 1R-visual guidence to the soma inducing a burst 
of mIPSCs of larger amplitude than those recorded in control. B. Lucifer yellow 
fluorescence AF indicating the extent of sucrose solution spreading (scale bar = 
5 pM). C. Scatter plot of 10-90% rise time versus amplitude in control and 
during sucrose application. D. Average mIPSCs for events collected in control 
(thin line) and during sucrose application (thick line). Distribution of mIPSC 
amplitude (E.) and rise time (F.) in control and during sucrose application.
Peak Amplitude (pA) Rise Time (ms)
Figure 5.11. Focal dendritic application of hypertonic sucrose.
A. Sucrose was applied under IR-visual guidence to a region of dendrite 
inducing a burst of mIPSCs of similar amplitude than those recorded in 
control. B. Lucifer yellow fluorescence AF indicating the extent of sucrose 
solution spreading (scale bar = 5 pM). C. Scatter plot of 10-90% rise time 
versus amplitude in control and during sucrose application. D. Average 
mIPSCs for events collected in control (thin line) and during sucrose 
application (thick line). Distribution of mIPSC amplitude (E.) and rise time 
(F.) in control and during sucrose application.
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but more slower rising events in control than in sucrose (Figure 5.1 l.F). This is 
probably a result of applying sucrose focally to an area of primary dendrite rather 
than to secondary and more distal dendritic regions, due to limitations of the 
visualisation technique used. The effects of cable filtering, evident in the spread of 
rise time of control population would not be evident or would be expected to be 
reduced by inducing mIPSCs selectively from this proximal dendritic region. The 
fact that the amplitudes of the events recorded in control and sucrose are the same, 
indicates that in both cases the smaller dendritic synapses were activated only.
These results indicate that the low frequency pure GABAa mIPSCs which have large 
amplitudes, occur at synapses on or very close to the soma of CeL neurones, whereas 
the predominant population of mixed receptor mIPSCs result from synapses 
localised dendritically.
5.2.5. Lateral stimulation activates dendritic mixed GABA receptor synapses
The IPSC described in the previous chapter were stimulated electrically in the ICM 
area lying between the CeL and the LA. These compound IPSCs were found to be 
partially blocked by bicuculline in all cases (n = 19), with an average block of 66.9 ± 
3.3 % (Figure 4.7.), and by TPMPA in all cases (n = 6) with an average block of 
36.8 ± 2 % (Figure 4.11.). The uniform block of the control mIPSC population 
(Figure 5.5.B) (when the pure GABAa mIPSCs of somatic synapses are seen very 
rarely or not at all) indicates that each individual synapse activated contains a 
proportion of both GABA receptors. To confirm this, the bicuculline and TPMPA 
sensitivity of small unitary minimal stimulation IPSC was examined. These minimal 
inputs were generated by incrementally increasing the electrical stimulus until an 
initial response is generated. The stimulus strength/response curves were generated 
(Figure 5.12.A) and the smallest consistent evoked response was used to examine the 
effects of the antagonists (excluding failures from the averages).
In all cases (8 minimal stimulation inputs in 7 neurones) a partial block of the 
laterally stimulated minimal IPSC was seen on addition of 10 pM bicuculline 
(Figure 5.12.B) and TPMPA. The average block by bicuculline was 71.1 ± 3.7 % of 
control peak amplitude (p < 0.01, n = 8) which is similar to the average block of the
A
Figure 5.12. Laterally evoked minimal IPSCs are partially blocked by either 
bicuculline or TPMPA.
A. Stimulus response curve for stimulation of minimal evoked IPSCs in the 
ICM region lateral to the CeL (recorded in 2 mM kynurenic acid), and minimal 
input recorded with 3.5 V stimulus. Minimal stimulation IPSCs (average 
responses shown) are partially blocked by bicuculline (B.) or TPMPA (C.) (n = 
8 and 4 respectively).
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compound IPSC recorded previously. The TPMPA block of 46.9 ± 9.7 %, (n = 4, p < 
0.05), was slightly higher than the block of the compound IPSC as a slightly higher 
concentration of TPMPA was used in the later experiments to ensure complete block 
of the bicuculline insensitive receptors (100 pM compared to 60 pM). These results 
indicated that these responses were partially mediated by both GABA receptors. 
Furthermore, the average amplitude of these minimal stimulation events (19.3 ± 3.8 
pA, n = 10) was much smaller than the amplitudes of the mIPSCs induced by 
somatic sucrose application but not significantly different from the average control 
mIPSC without sucrose (20.4 ± 2.1 pA).
5.2.6. Medial stimulation activates somatic GABAa synapses
With the aim of identifying alternate inhibitory inputs into the CeL, electrical 
stimulation in various positions around the circumference of the Ce and in the CeM, 
were performed in the presence of kynurenic acid (2 mM). Monosynaptic IPSCs 
were stimulated with the stimulating electrodes place within the CeM and in the area 
medial to the CeM. Minimal stimulation responses generated here were larger and 
faster rising IPSC than those evoked by the lateral stimulation, as represented by the 
typical response shown in Figure 5.13.A. The average amplitude of the medial 
minimal stimulation response was 130.8 ± 13.4 pA and the rise time 1.7 ± 0.1ms (n 
= 10) compared to 19.3 ± 3.8 pA and 3.19 ± 0.4 ms for the lateral inputs (Figure
5.13. B,C). In contrast to the lateral responses, the medial minimal stimulation inputs 
were unaffected by TPMPA (1.1 ± 3.2 % inhibition, n = 3, Figure 5.13.D), but 
completely blocked by 10 pM bicuculline (98.3 ± 3 %, p < 0.01, n = 7, Figure
5.13. E). These results indicate that these evoked IPSC, like the fast rising 
spontaneous events induced by somatic application of sucrose, are also mediated by 
GABAa receptors only.
5.2.7. Effect of Diazepam on lateral and medial IPSC.
In the previous chapter, the effect of the 1,4-benzodiazepines diazepam and 
flurazepam was shown to be inhibitory on the bicuculline resistant receptors, while it 
positively modulated the GABAa receptors (Figure 4.15. and 4.16.). To compare the
MEDIAL LATERAL MEDIAL LATERAL
Control + TPMPA Control + BIC
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50 ms
Figure 5.13. Medially evoked minimal IPSCs are larger and faster rising than 
those evoked laterally , and are blocked by bicuculline only.
A. Stimulus response curve for stimulation on the medial edge of the central 
amygdala, and the average of six medial minimal stimulation IPSCs stimulated 
(recorded in 2 mM kynurenic acid). Average amplitude (B.) and rise time (C.) 
of medially evoked minimal IPSCs compared to those evoked laterally.
D. Averages of six medially stimulated minimal IPSCs in control (2 mM 
kynurenic acid) and in TPMPA (100 pM). E. Averages of six medially 
stimulated minimal IPSCs in control and blocked by bicuculline (10 pM).
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net effects of these drugs on laterally and medially inhibitory stimulated synapses, 
they were applied to minimal stimulation responses stimulated from both aspects.
Application of diazepam to the laterally stimulated minimal IPSC (Figure 5.14.A) 
resulted in a decrease in peak amplitude, but an increase in 1/2 peak width. The 
average effects for 5 cells being an 18.8 ± 7.5% decrease in amplitude and a 44.3 ± 
16.2% (p < 0.05) increase in 1/2 peak width (Figure 5.14.C). In contrast, application 
of diazepam to the medially stimulated minimal IPSC (Figure 5.14.B) increased in 
both amplitude (13.7 ± 10.1%) and 1/2 peak width (39.7 ± 7.1%, p < 0.01, n = 6) 
(Figure 5.14.C).
These results are consistent with the medially stimulated IPSC being mediated by 
GABAa receptors only, which are positively modulated by diazepam, and the lateral 
IPSC being mediated by a mixed receptor population, which is both positively and 
negatively modulated, resulting in a net decrease in amplitude but an increase in 1/2 
width of these IPSC.
5.3. DISCUSSION
5.3.1. Two types of inhibitory synapses on CeL neurones
These experiments indicate that the inhibitory synapses on CeL neurones fall into 
two catagories -  pure GABAa and mixed GABA receptor synapses.
The mixed receptor synapses which express both the GABAa and bicuculline 
insensitive GABA receptors are partially blocked by either bicuculline or TPMPA 
with a consistent average contribution of the GABAa receptors of approximately 
66% of the response. These synapses mediate the vast majority of the spontaneous 
inhibitory activity affecting the cell and afferents to these synapses can be stimulated 
electrically by in the ICM regions lateral to the Ce. The amplitude and 
bicuculline/TPMPA sensitivity of control mIPSCs is not significantly different from
A  n Lateral control normalisedDiazepam
30 ms
B Medial control Diazepam normalised
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Figure 5.14. Diazepam reduces laterally evoked IPSCs but increases IPSCs 
evoked medially.
A. Typical laterally evoked minimal IPSCs in control and in diazepam (10 
pM), and normalised (averages of six individual IPSCs shown). B. Typical 
medially evoked minimal IPSCs in control and in diazepam (10 pM), and 
normalised (averages of six individual IPSCs shown). C. Average effects 
of diazepam on laterally and medially evoked IPSC amplitude and 1/2 
width (p < 0.05, n = 6 and p < 0.01, n = 6 respectively).
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those of unitary IPSC responses to minimal stimulation of these lateral afferents, 
indicating that control mIPSCs are spontaneous activation of the same synapses. The 
rise time of spontaneous events and evoked responses from these synapses is slow 
indicating dendritic origin. This is further demonstrated by increased spontaneous 
activity of similar amplitude and rise time resulting from dendritic application of 
hypertonic sucrose. These synapses thus have been demonstrated as dendritic, mixed 
GABA receptor synapses, whose afferents arrive from the lateral aspect of the CeL 
and release spontaneously at high frequency.
The pure GABAa synapses were found to be activated at very low frequency in 
control conditions, but at higher frequency when hypertonic sucrose was applied to 
the somata of the CeL neurones. These mIPSCs, like the evoked IPSCs resultant 
from electrical stimulation on the medial aspect of the Ce or in the CeM, were 
completely bicuculline sensitive and TPMPA insensitive. Both the somatic sucrose 
induced mIPSCs and the medially evoked IPSCs were larger and faster rising than 
the dendritic mixed receptor IPSCs confirming the proximity of these synapses to the 
soma. Thus in summary, medially arriving afferents make somatic inhibitory 
synapses on CeL neurones producing large synaptic currents which are mediated by 
GABAa receptors only and activated at very low frequency in control conditions. 
Dendritic inhibitory synapses are mixed GABA receptor synapses which are made 
with local inhibitory intemeurones. These inputs may be stimulated directly laterally 
in the ICM region, or by stimulation of a disynaptic circuit from the basolateral 
complex.
5.3.2. Two inhibitory inputs to CeL neurones
Axonal tracing studies have revealed several potential inputs, other than those from 
the basomedial amygdaloid complex, which may potentially form these somatic 
GABAa inhibitory synapses. Ascending projections from various brainstem and 
hypothalamic nuclei have been demonstrated to project heavily into all divisions of 
the Ce. A feedback inhibitory input from these ascending pathways may well 
provide powerful and acute inhibitory control over the output of the CeL to shut 
down CeL mediated effects on autononic pathways originating in the brainstem and 
hypothalamus. Tracing studies have shown that the passage of axons involved in
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these ascending pathways enter into the amygdala via an area medial to the CeM, 
and dorsal to the medial nucleus of the amygdala, corresponding to the region 
between ansa lenticularis and the basal nucleus Meynert (Paxinos & Watson, 1986). 
This region corresponds to the region stimulated electrically in the medial 
stimulation somatic inhibitory synapses.
The afferents to the mixed receptor synapses were stimulated in the area 
corresponding to the location of the ICM, situated laterally to the Ce. These IPSC 
were also stimulated as a disynaptic input by stimulating in the BLA or LA (Figure 
3.5.). Royer et al have shown in guinea pig that stimulation in the LA and BLA 
elicites a feed forward IPSC in CeM neurones from GABAergic ICM neurones 
which is partly bicuculline insensitive (Royer et al., 1999). ICM neurones were also 
shown to projecting locally into the CeL (Royer et al., 1999) which may similarly 
innervate the mixed receptor synapses on the CeL. Alternately, LA neurones have 
been shown to project to the CeL in cat (Smith & Pare, 1994) and the capsular 
region of the CeL in rat (Pitkänen et al., 1995). It is thus, also possible that the 
stimulation in the ICM region may have stimulated GABAergic neurones on the 
lateral edge of the CeL itself (capsular region), though the comparatively light 
projection from the capsular area to the rest of the CeL shown by Jolkannen and 
Pitkanen (1998) would make this unlikely.
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6. GENERAL. DISCUSSION
The research embodied in this thesis has in the main part investigated the inhibitory 
transmission that occurs in the lateral division of central amygdala. From this 
research three notable findings have been made; CeL fast inhibitory transmission is 
mediated by two pharmacologically distinct subtypes of GABA receptors, these 
receptors are colocalised at dendritic synapses while somatic synapses contain 
GABAa receptors only, and medially arriving inhibitory inputs selectively activate 
these somatic synapses, whereas input from the lateral input activate the dendritic 
synapses.
The presence of a novel type of inhibitory' response was first noticed by Nose et al 
(1991), who described strychnine sensitive IPSCs that were not blocked by 
bicuculline. While the presence of glycine receptors on CeL neurones was 
demonstrated, no evidence of their participation in the synaptic inhibitory currents 
was found. Rather, the bicuculline insensitive inhibitory currents presumably 
underlying the bicuculline insensitive IPSP reported by Nose et al (1991) were 
demonstrated to be mediated by a GABA receptor. This receptor subtype is distinct 
from typical GABAa receptors in that it is insensitive to low concentrations of 
bicuculline but sensitive to TPMPA, it is less sensitive to barbiturate modulation and 
insensitive to anaesthetic modulation, and it is negatively modified by classical 1,4- 
benzodiazepines. The central amygdala has been demonstrated to contain very high 
density of GABAergic cells, GABAergic terminals (Nitecka & Ben-Ari, 1987) and 
benzodiazepine binding sites (Niehoff & Kuhar, 1983). Furthermore, 
benzodiazepines have been used for some time to treat anxiety disorders which have 
been suggested to result from dysfunction of the amygdala (Davis, 1992; LeDoux, 
1996). The presence in this structure of a high density of GABA receptors, which 
are not potentiated by these drugs but inhibited by them, may indicate that the action 
of these drugs is more complex than previously thought. Also, the isolation and 
identification of the GABA receptor subunit structure of these receptors may 
provide new insights into the action of allosteric modulators of GABA receptors and 
perhaps lead to the development of new therapeutic agents directed specifically at 
these receptors.
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The segregation of GABAa receptor subtypes at particular postsynaptic sites has 
been demonstrated immunohistochemically (Fletcher et al., 1998; Gustincich et al., 
1999; Nusser et al., 1996), and more indirectly by examining the kinetic changes 
associated with post-translational modification of particular subunit combinations 
(Nusser et al., 1999). GABAc receptors have also been demonstrated to be either 
localised at separate synapses to GABAa receptors in the retina (Fletcher et al., 
1998; Koulen et al., 1998). The pharmacological demonstration of co-localisation of 
the two GABA receptor at dendritic synapses, but exclusion of the bicuculline 
resistant type at particular somatic synapses is further evidence that GABA receptor 
subcellular localisation is highly organized. The functional benefit of having 
multiple receptors with different regulatory or kinetic properties at particular 
synapses may provide a means for increasing or decreasing synaptic strength at 
these sites selectively. For instance, if a mixed synapse contained a receptor type 
that was inhibited by a naturally occurring allosteric modulator (such as a 
neuroactive steroid, a naturally occurring benzodiazepine site ligand (Medina et al., 
1993) or Zn2+ (Perez-Clausell et al., 1989)) and one that was positively modulated, 
and another synapse contained only receptors that were positively modulated, the 
effect of such a modulator would be a net effect at the mixed synapse, depending on 
the receptor proportions, but positive at the single receptor synapse. Thus, this 
inhibitory pathway may be selectively enhanced by these agents over the pathway 
through the mixed synapse. Furthermore, increasing the proportion of the receptor 
inhibited by the allosteric modulator may provide a means for down-regulating the 
inhibition through this pathway when these modulators are present. The 
demonstration that applying benzodiazepines to the dendritic synapse IPSC 
activated by lateral stimulation reduced amplitude and increased decay less that that 
of the medially stimulated somatic synapses, which are also increased in amplitude, 
may illustrate this. Another possibility for mixed synapses is that one of the receptor 
types has higher sensitivity for GABA and/or exhibits less desensitisation (as is the 
case for p 1 GABAc receptors), and that including more of this receptor in a mixed 
synapse may increase the sensitivity of these sites to low concentrations of GABA 
(perhaps increasing responses to GABA spillover), or to increase the duration of the 
inhibitory responses occurring at these sites (Sheilds et al., 2000).
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Finally, this research demonstrated that the CeL receives inhibitory input from the 
basolateral amygdaloid complex (albeit indirectly through the 1CM neurones) and 
inhibitory input from a pathway that arrives medially. In the context of the known 
sources of innervation of these neurones, there are two likely candidates for the 
origin of these fibres. Firstly, the concept of the central extended amygdala includes 
an interconnected group of nuclei (the Ce, BNST and SI) which all receive similar 
afferents and project to similar effector regions in the brainstem and hypothalamus. 
The nature of the interconnections within the CEA has been described as an intrinsic 
system of GABAergic projections (Cassell et al., 1999), which may integrate the 
output of the CEA. The second potential source of inhibition for these neurones may 
be the brainstem. These inputs may be reciprocal connections from the primary 
target areas of the Ce in the brainstem or alternatively they may be primary input 
arriving from the parabrachial nucleus as part of the nociception pathway. The latter 
pathway in particular may rapidly inhibit the locally projecting inhibitory network, 
causing rapid disinhibition of the projection neurones of the CEA. Such a pathway 
would require rapid and strong inhibition of these intrinsic GABAergic 
interneurones. Large inhibitory synapses on the soma or perhaps on the spine 
structures of the initial segments of the neurones would be ideally placed to mediate 
this rapid and complete inhibition. This pathway would be ideally placed to initiate 
protective arousal effects associated with unconditioned startle responses, which are 
independent of basolateral amygdaloid processing (Davis & Shi, 1999). Furthermore 
it has been suggested that the central amygdala may contribute to the plasticity that 
underlies the conditioned fear response, through the convergence of the 
unconditioned stimulus arriving from the parabrachial nucleus and conditioned 
stimulus pathways arriving via the thaiamus, cortex and basolateral amygdaloid 
complex (Kapp et al., 1992). Thus, convergence of excitation via the BLC and 
disinhibition within the CEA may provide a mechanism for conditioning.
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GABA Receptors inhibited by Benzodiazepines Mediate Fast 
Inhibitory Transmission in the Central Amygdala
Andrew J. Delaney and Pankaj Sah
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The amygdala is intimately involved in emotional behavior, and 
its role in the generation of anxiety and conditioned fear is weil 
known. Benzodiazepines, which are commonly used for the 
relief of anxiety, are thought to act by enhancing the action of 
the inhibitory transmitter GABA. We have examined the prop­
erties of GABA-mediated inhibition in the amygdala. Whole-cell 
recordings were made from neurons in the lateral division of the 
central amygdala. Application of GABA evoked a current that 
reversed at the chloride equilibrium potential. Application of the 
GABA antagonists bicuculline or SR95531 inhibited the GABA- 
evoked current in a manner consistent with two binding sites. 
Stimulation of afferents to neurons in the central amygdala 
evoked an IPSC that was mediated by the release of GABA. The 
GABAa receptor antagonists bicuculline and picrotoxin failed to
completely block the IPSC. The bicuculline-resistant IPSC was 
chloride-selective and was unaffected by GABAB-receptor an­
tagonists. Furthermore, this current was insensitive to modula­
tion by general anesthetics or barbiturates. In contrast to their 
actions at GABAa receptors, diazepam and flurazepam inhib­
ited the bicuculline-resistant IPSC in a concentration- 
dependent manner. These effects were fully antagonized by the 
benzodiazepine site antagonist Ro15-1788. We conclude that a 
new type of ionotropic GABA receptor mediates fast inhibitory 
transmission in the central amygdala. This receptor may be a 
potential target for the development of new therapeutic strate­
gies for anxiety disorders.
Key words: GABAC; fear; anxiety; diazepam; bicuculline; 
amygdala
G A B A  is the major inhibitory transmitter in the mammalian CNS 
(Nicoll et al., 1989). As with many other types o f receptor, two 
broad types of G A B A  receptor are recognized: ionotropic ligand- 
gated channels and metabotropic G-protein-coupled receptors. 
Ionotropic G A B A  receptors are further subdivided into the 
bicuculline-sensitive G A B A a receptors (MacDonald and Olsen, 
1994; Johnston, 1996a) and the bicuculline-insensitive GABA(- 
receptors (Qian and Dowling, 1994; Bormann and Feigenspan, 
1995). G A B A a  receptors gate a chloride ionophore and have 
modulatory binding sites for benzodiazepines, barbiturates, and 
anesthetics, all o f which potentiate the response to G ABA (Mac­
Donald and Olsen, 1994; Johnston, 1996a). These receptors are 
potently inhibited by the competitive antagonists bicuculline and 
SR95531 and the plant alkaloid picrotoxin (Sieghart, 1995).
G A B A a  receptors are assembled from a large family of which 
fifteen members have so far been identified: 6a, 4/3, 3y, 18, and le 
(Barnard et al., 1998). Heterologous expression of different sub­
units has shown that functional G ABA receptors can form as 
homomers or as heteromultimers of different subunits. However, 
most G A B A a  receptors in the CNS are thought to contain both 
a and ß subunits, w ith one or more of the y, 8, or e subunits 
(Barnard et al., 1998). The subunit combination o f a particular 
G A B A  receptor determines its pharmacological properties (Cos-
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ta, 1998; MacDonald and Olsen, 1994). For example, amplifica­
tion of GABA action by benzodiazepines is only seen in receptors 
that contain one of al, a2, a5 subunits and either a y2 or a y3 
subunit. Receptors that contain a4, a6, or yl are unaffected by 
benzodiazepines (MacDonald and Olsen, 1994; Costa, 1998).
GABAC receptors also gate a chloride channel, but they are not 
blocked by bicuculline or SR95531, and are markedly less sensi­
tive to picrotoxin. They are also insensitive to modulation by 
benzodiazepines and barbiturates (Qian and Dowling, 1993; Bor­
mann and Feigenspan, 1995; Johnston, 1996b). G ABAC receptors 
are assembled from p subunits (p i, p2, p3), which share some 
homology with G A B A a receptor subunits, but do not appear to 
coassemble with them. G ABAc receptors have only clearly been 
demonstrated in the retina (Qian and Dowling, 1994; Enz et al., 
1995). Bicuculline-resistant responses to G ABA have been re­
ported in several brain regions (Drew et al., 1984; Arakawa and 
Okada, 1988; Strata and Cherubini, 1994). However, the impor­
tance of these receptors outside of the retina has yet to be 
demonstrated.
The amygdala is intimately involved in emotional behavior, and 
its role in the generation of anxiety and conditioned fear is well 
known (Klüver and Bucy, 1939; LeDoux, 1995). Benzodiaz­
epines, which are commonly used for the relief of anxiety, are 
thought to produce their therapeutic effect by enhancing the 
action of G ABA (Tallman and Gallager, 1985; Costa and 
Guidotti, 1996). The action of benzodiazepines on G ABA recep­
tors within the amygdala is likely to be responsible for the anti­
anxiety action of these agents because binding sites for benzodi­
azepines are present in the amygdala at high density (Niehoff and 
Kuhar, 1983; Richards and Möhler, 1984). In this study we have 
examined the properties of ionotropic G ABA receptors in the 
central amygdala. We find that neurons in the central amygdala
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(Hamann et al., 1988). On average, 10 jxM BIC blocked the 
GABA-activated current by 65 ± 6%, and 100 jxm by 92 ± 3% 
(n = 11; Fig. 1£); 1 and 10 /xm SR95531 blocked the iontophoretic 
current by 77 ± 6 and 93 ± 6% (n = 3), respectively. These 
results suggest that two types of ionotropic GABA receptor are 
present on CeL neurons. To rule out the possibility that the low 
sensitivity of the GABA response might be caused by inadequate 
access of the bath-applied antagonists to their site of action, we 
examined a block of iontophoretically applied glycine by the 
selective antagonist strychnine. Glycine activated a chloride- 
mediated current in all cells tested (data not shown). Strychnine 
blocked this current at a single, high-affinity site with an IC50 of 
79 nM (Fig. ID), close to the reported IC50 for strychnine in 
isolated cells and membrane patches (Shirasaki et al., 1991; Jonas 
et al., 1998). At 10 /xm BIC, the contribution of the high-affinity 
BIC sites to the GABA response will be negligible. We therefore 
used this concentration of BIC to examine the properties of the 
BIC-resistant GABA response.
The relative insensitivity of the GABA response to BIC and 
SR95531 suggests that a GABAC like receptor might be present. 
GABA«^ receptors can be blocked by high concentrations of 
picrotoxin (Polenzani et al., 1991) and the selective antagonist 
TPM PA (Ragozzino et al., 1996). In confirmation of this, we 
found that the GABA response resistant to BIC was blocked by 
88 ± 1% by 100 /xm picrotoxin (n = 3) and by 73 ± 1% by 60 /xm 
TPM PA (n = 3; Fig. 2). These results show that iontophoretically 
applied GABA activates two pharmacologically distinct recep-
Control
_ _ i l 0 0  pA
TPMPA
_|50 pA
500 ms 100pM 60|xM 
PTX TPMPA
Figure 2. G A BA  -like receptors are present in the central amygdala. A, 
Responses to iontophoretically applied GABA recorded in control, 10 /xM 
bicuculline, and 100 /xM picrotoxin. B, The trace on the left is the response 
to iontophoretically applied GABA in the presence of 10 jxm BIC. This 
current is blocked by application of the selective GABA«-- antagonist 
TPMPA (60 p.M). C, Summary data showing the average reduction of the 
BIC-resistant response by picrotoxin and TPMPA.
tors. One has a high affinity for BIC and SR95531, and represents 
activation of GABAa receptors, the other is relatively resistant to 
BIC and SR95531 but is antagonized by TPMPA.
We next asked if these two types of GABA receptor were also 
activated by synaptically released GABA. Stimulation of local 
afferents in the presence of glutamatergic antagonists evoked an 
IPSC that reversed near the chloride equilibrium potential (Fig. 
3/1,ß), showing that it is a chloride-selective current. Application
Figure 3. GABAergic inhibitory synaptic 
currents in the central amygdala are not 
blocked by low doses of bicuculline or 
picrotoxin. A, Synaptic currents in re­
sponse to local electrical stimulation in 
the presence of blockers of glutamatergic 
receptors (see Materials and Methods) re­
corded at membrane potentials of —80, 
-6 0 , -4 0 , -2 0 , 0, and 10 mV using low- 
chloride internal solution. B, Normalized 
current-voltage relationships for synaptic 
currents recorded using low-chloride 
(closed circles) (n =  4) and high-chloride 
internal solutions (open squares) (n =  2). 
The reversal potential in low-chloride in­
ternal was -5 2  mV, whereas in high- 
internal chloride it was 0 mV. C, Average 
CeL IPSCs recorded in control, in 10 /xM 
bicuculline, and in 100 /xm  bicuculline. 
The IPSC was blocked to 67 ± 3% of 
control by 10 jxm and 87 ± 3% in 100 /xm  
BIC. D, IPSCs recorded in control, in 25 
/xM picrotoxin (PTX), and 100 /xM PTX. 
IPSC amplitude was blocked by 64 ± 0% 
in 25 /xm  PTX. E, Summary of effects of 
antagonists bicuculline and picrotoxin on 
IPSC peak amplitude recorded from CeL 
neurons ( filled columns) or from CA1 py­
ramidal neurons (open columns) (n = 5, 3, 
3, 7, 5, and 4, respectively).
A
Vm (mV)
normalised
current
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Figure 6. Diazepam and flurazepam in­
hibit GABAc receptors in the central 
amygdala. A, The effect of flurazepam on 
the BIC-resistant IPSC. Flurazepam (1 
/a m ) reduced the peak amplitude (37 ± 
5% of control; n = 9) with no effect on the 
kinetics of the current. B, The benzodiaz­
epine site antagonist Rol5-1788 (1 /a m ) 
has no effect on IPSC amplitude but 
blocks the inhibitory effect of flurazepam. 
After washout of Rol5-1788, a second 
application of flurazepam now inhibits the 
IPSC. Individual records taken from the 
times indicated are shown above. C, Sum­
mary data showing the effects of fluraz­
epam and diazepam on BIC-resistant 
IPSCs in control conditions (n = 9) and 
Ro 15-1788 (n = 3). D, The effects of 
benzodiazepines are postsynaptic because 
diazepam (10 /a m ) blocks the bicuculline- 
resistant response to iontophoretically ap­
plied GABA by 27 ± 8% (n = 5).
A 3|c Flurazepam Flurazepam
10 20 
time (min)
duced by 21.2 ± 7.4% ( p  = 0.16), and half-width increased by 
32 ±  16% (n = 3; p  = 0.07; Fig. 5E,F).
T he 1,4-benzodiazepines act as positive modulators of some 
G A B A a receptors (M acD onald and Olsen, 1994; Costa, 1998) by 
increasing the affinity of the receptor for GABA (Lavoie and 
Twym an, 1996), whereas G A BAC receptors are insensitive to 
these agents. In the C eL, flurazepam  (1 /am) reduced the ampli­
tude of the B IC -resistant IPSC  by 37 ± 5% (n = 9; Fig. 6/4). 
D iazepam  (1 /am), another 1,4 benzodiazepine, reduced the am­
plitude of the B IC -resistant IPSC by 28 ± 7%, and 10 /am 
diazepam  reduced it by 42 ± 5%  (n =  5; Fig. 6C). This effect was 
fully antagonized by the benzodiazepine receptor antagonist Ro 
15-1788 (H unkeler et al., 1981) (Fig. 6C), showing that it was not 
a nonspecific action of these benzodiazepines. T here was no 
effect on the kinetics of the IPSC with either diazepam  or 
flurazepam  (Fig. 6/4,C). To confirm that the effects of the ben­
zodiazepines on IPSC  am plitude were caused by their postsyn­
aptic actions on G A B A  receptors, we tested the action of diaze­
pam on iotophoretically applied GABA. D iazepam  (10 jam) 
reduced the am plitude of the BIC-resistant GABA-evoked cur­
rent by 27 ± 8% (n =  5; Fig. 6D), showing that the effects of 
diazepam  are postsynaptic.
We perform ed two control experim ents to ensure that the 
benzodiazepines were active at G A BA a receptors in our hands. 
First, we checked the action of these drugs on G A B A a synapses 
recorded from CA1 neurons in the hippocampus. Diazepam  (1 
/am) increased the am plitude of hippocampal G A B A a receptor- 
m ediated IPSC s by 34 ±  16% and its half decay by 17 ± 12% 
(n =  5), and at 10 /x m ,  the IPSC amplitude and half width 
increased by 41 ± 16 and 28 ± 18%, respectively (data not 
shown). These effects are typical of the actions of benzodiaz­
epines at G A B A a synapses (O tis and Mody, 1992; Z hang et al., 
1993). Second, we isolated the G A B A A-mediated IPSC in CeL 
neurons by perform ing experim ents in the presence of TPM PA. 
TPM  PA (60 /am) blocked the control IPSC by 27 ± 2% (n = 4). 
In the presence of TPM  PA, bicuculline (10 /am) blocked the IPSC 
(96 ±  1% of control; Fig. 7/4), confirming it was caused by
activation of GABAa receptors. Application of flurazepam  in the 
presence of TPM  PA had no effect on the peak amplitude but 
increased the half width of the IPSC by 121 ± 5% (n = 3; Fig. 
IB), showing that GABAa receptors that contribute to the IPSC 
have a typical pharmacology.
DISCUSSION
We have shown that in the CeL, both exogenously applied G A B A  
and synaptically released G A BA activate two types of ionotropic 
GABA receptor. One is a classical G A B A a receptor, inhibited by 
BIC and positively modulated by benzodiazepines. T he o ther is 
relatively insensitive to the classical GA BA a receptor antagonists 
bicuculline and picrotoxin. T his BIC-insensitive response is 
blocked by the GABA^- antagonist TPM  PA. Furtherm ore, like 
G A B A c receptors, the BIC-insensitive com ponent is not affected
Control TPM PA BIC
__|200 pA
50 ms
Figure 7. Pharmacology of GABAa receptors in the CeL. GABAa 
receptors were isolated by blocking GABAf- receptors with TPM PA (60 
/a m ) . A, The IPSC remaining in the presence of TPMPA is effectively 
inhibited by 10 /a m  bicuculline. B, The GABAa receptor-mediated IPSC 
is positively modulated by benzodiazepines. Flurazepam had no effect on 
peak amplitude but increased the half width by 121 ± 5%.
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